ELAVL3

UniProt ID: Q14576
Organism: Homo sapiens
Review Status: COMPLETE
πŸ“ Provide Detailed Feedback

Gene Description

ELAVL3 (HuC) is a neuron-specific RNA-binding protein with three RNA recognition motifs (RRMs) and a hinge/linker region that binds to AU-/U-rich elements in the 3'-UTRs of target mRNAs to regulate mRNA stability, alternative splicing, alternative polyadenylation (3'-UTR length choice), and transcript abundance. RRM1 and RRM2 directly associate with AU-rich RNA, while RRM3 promotes transcript stability via poly(A)-tail-associated mechanisms. ELAVL3 is predominantly cytoplasmic but shuttles between nucleus and cytoplasm via signals in the hinge region. It plays essential roles in neuronal differentiation, maintenance, and synaptic integrity, particularly in the cerebellum and hippocampus; ELAVL3 loss perturbs splicing programs converging on glutamate regulation and neuronal excitability (e.g., AnkG exon 34 mis-inclusion), producing seizures and cerebellar ataxia in knockout models.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0140517 protein-RNA adaptor activity
IBA
GO_REF:0000033
ACCEPT
Summary: IBA annotation for protein-RNA adaptor activity based on phylogenetic inference. ELAVL3 functions as an RNA-binding protein that binds AU-rich elements in 3'-UTRs and regulates mRNA stability and processing, consistent with adaptor activity.
Reason: This term accurately captures ELAVL3's core molecular function as a protein that mediates interactions between RNA molecules and other cellular components through its RNA-binding activity. The deep research confirms ELAVL3 "binds preferentially to GU-rich and AU-rich sequences in intronic regions and 3'-untranslated regions (3'-UTRs) of target pre-mRNAs" and "regulates alternative splicing, mRNA stability, and transcript abundance". UniProt confirms it "binds to AU-rich element (ARE) sequences of target mRNAs" [PMID:10710437]. IBA annotations are typically well-curated and phylogenetically sound.
Supporting Evidence:
PMID:10710437
HuC and HuD bind to the VEGF 3'-UTR regulatory segment (VRS) and to the c- myc 3'-UTR in a specific and concentration-dependent pattern
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
ELAVL3 binds preferentially to GU-rich and AU-rich sequences in intronic regions and 3'-untranslated regions (3'-UTRs) of target pre-mRNAs. This binding regulates alternative splicing, mRNA stability, and transcript abundance
file:human/ELAVL3/ELAVL3-deep-research-falcon.md
ELAVL3 functions primarily as a post-transcriptional regulator that stabilizes target transcripts, in part by binding AU-rich elements and influencing poly(A)-tail-associated protection; ELAVL proteins can multimerize on RNA and oppose destabilizing factors.
PMID:37697079
Binding to RNA targets is facilitated by the RRM1 and RRM2 domains preferentially recognising AU-rich elements in the 3ΚΉUTR of transcripts
GO:0003676 nucleic acid binding
IEA
GO_REF:0000002
MODIFY
Summary: IEA annotation for nucleic acid binding based on InterPro domain assignment. This is a very general parent term for RNA binding.
Reason: While technically correct (ELAVL3 does bind nucleic acids), this term is too broad and uninformative. ELAVL3 specifically binds RNA, not DNA, through its three RRM domains. The more specific term GO:0003723 (RNA binding) is already annotated and better represents the actual molecular function.
Proposed replacements: RNA binding
Supporting Evidence:
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
ELAVL3 contains three RNP-type RNA recognition motifs (RRMs), which are responsible for its RNA-binding activity
GO:0003723 RNA binding
IEA
GO_REF:0000120
ACCEPT
Summary: IEA annotation for RNA binding from combined automated annotation methods. This is appropriate but less specific than the available AU-rich region binding terms.
Reason: This term accurately describes ELAVL3's core molecular function. ELAVL3 contains three RRM domains that bind RNA, specifically to AU-rich and GU-rich sequences in mRNA 3'-UTRs. While more specific terms exist (mRNA 3'-UTR AU-rich region binding), this general RNA binding term is acceptable and correct as a broader classification.
Supporting Evidence:
PMID:10710437
These proteins bind to AU-rich elements in the 3'-untranslated regions (3'-UTRs) of many growth-related mRNAs, including c-myc and VEGF
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
ELAVL3 contains three RNP-type RNA recognition motifs (RRMs), which are responsible for its RNA-binding activity
PMID:37697079
All four ELAVL proteins share a common basic structure, of three RNA recognition motif (RRM) binding domains and a hinge region
GO:0003730 mRNA 3'-UTR binding
IEA
GO_REF:0000117
ACCEPT
Summary: IEA annotation for mRNA 3'-UTR binding from ARBA machine learning models. This accurately captures ELAVL3's specific binding preference for 3'-UTR regions.
Reason: This is a highly specific and accurate molecular function term for ELAVL3. Multiple lines of evidence demonstrate that ELAVL3 preferentially binds to AU-rich elements located in the 3'-UTRs of target mRNAs including VEGF and c-myc. This is a core molecular function of the protein.
Supporting Evidence:
PMID:10710437
HuC and HuD bind to the VEGF 3'-UTR regulatory segment (VRS) and to the c- myc 3'-UTR in a specific and concentration-dependent pattern
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
ELAVL3 binds preferentially to GU-rich and AU-rich sequences in intronic regions and 3'-untranslated regions (3'-UTRs) of target pre-mRNAs
GO:0007399 nervous system development
IEA
GO_REF:0000043
ACCEPT
Summary: IEA annotation for nervous system development based on UniProtKB keyword mapping. ELAVL3 is neuron-specific and plays roles in neuronal differentiation and maintenance.
Reason: This biological process term is well-supported. ELAVL3 is brain-specific and essential for neurogenesis, neuronal differentiation, and maintenance of neurons. The deep research indicates ELAVL3 is "involved in the development and maintenance of neurons" and knockout mice exhibit severe motor deficits and cerebellar ataxia. UniProt states it "may be involved in neuronal differentiation and maintenance".
Supporting Evidence:
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
Neurogenesis: ELAVL3 is involved in the development and maintenance of neurons
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
ELAVL3 knockout mice exhibit progressive motor deficits, severe cerebellar ataxia, and Purkinje cell axonal degeneration
PMID:37697079
As Elavl3βˆ’/βˆ’ mice aged, progressive severe cerebellar ataxia was observed
PMID:37697079
At the cellular level, Purkinje neurons had disrupted synaptic formation, swollen axons, and overall deficits in neuronal transport, highlighting the requirement for Elavl3 activity in these neurons
GO:0030154 cell differentiation
IEA
GO_REF:0000043
MODIFY
Summary: IEA annotation for cell differentiation based on UniProtKB keyword mapping. This is a very general process term that applies to ELAVL3's role in neuronal differentiation.
Reason: While technically correct (ELAVL3 is involved in neuronal differentiation), this term is too broad and non-specific. The more precise term would be neuronal differentiation or neuron differentiation, which better captures ELAVL3's tissue-specific role. Given that ELAVL3 is brain-specific and specifically involved in neurogenesis, a more specific term should be used.
Proposed replacements: neuron differentiation
Supporting Evidence:
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
Neurogenesis: ELAVL3 is involved in the development and maintenance of neurons
PMID:37697079
Elavl3 expression is upregulated during the differentiation of neural stem cells into inhibitory GABAergic neurons, in parallel with 3’UTR lengthening. Depletion of Elavl3 during this differentiation process caused a shift towards using proximal polyA sites compared to control cells, with a concomitant delay in neural stem cell differentiation
GO:1990904 ribonucleoprotein complex
IEA
GO_REF:0000002
ACCEPT
Summary: IEA annotation for ribonucleoprotein complex based on InterPro domain assignment. This cellular component term reflects ELAVL3's association with RNA as an RNP complex component.
Reason: This is an appropriate cellular component annotation. ELAVL3 is an RNA-binding protein with RRM domains that forms ribonucleoprotein complexes with its target mRNAs. The deep research notes ELAVL3 binds over 1,100 transcripts in certain contexts, indicating it forms functional RNP complexes. While more specific localization terms could be added (nucleus, cytoplasm), this general RNP complex annotation is correct.
Supporting Evidence:
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
In neuroendocrine cancer cell lines, ELAVL3 binds over 1,100 transcripts, with enrichment for genes involved in neuron projection development and synapse organization
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
ELAVL3 is predominantly localized in the nucleus and cytoplasm of neurons throughout the brain
GO:0035925 mRNA 3'-UTR AU-rich region binding
IEA
GO_REF:0000107
ACCEPT
Summary: IEA annotation for mRNA 3'-UTR AU-rich region binding from Ensembl Compara orthology transfer. This is the most specific and accurate molecular function term for ELAVL3.
Reason: This is the most precise molecular function annotation for ELAVL3 and represents its core biochemical activity. ELAVL3 specifically binds to AU-rich elements (AREs) in the 3'-UTRs of target mRNAs. PMID:10710437 experimentally demonstrates HuC binding to AU-rich regions in VEGF and c-myc 3'-UTRs. The deep research confirms binding to "GU-rich and AU-rich sequences" in 3'-UTRs. This annotation captures the key sequence specificity that distinguishes ELAVL3 from general RNA-binding proteins.
Supporting Evidence:
PMID:10710437
These proteins bind to AU-rich elements in the 3'-untranslated regions (3'-UTRs) of many growth-related mRNAs, including c-myc and VEGF
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
ELAVL3 binds preferentially to GU-rich and AU-rich sequences in intronic regions and 3'-untranslated regions (3'-UTRs) of target pre-mRNAs
GO:0005515 protein binding
IPI
PMID:36950384
Protein interaction studies in human induced neurons indicat...
REMOVE
Summary: IPI annotation for protein binding based on physical interaction evidence from a large-scale proteomics study on autism spectrum disorders.
Reason: While ELAVL3 does interact with proteins (UniProt mentions MAP1B light chain LC1, and IntAct shows interactions with DYRK1A, SCN2A, SYNGAP1), the generic "protein binding" term is uninformative and does not describe a molecular function. This term should not be used unless referring to a specific functional role (e.g., as an adapter or scaffold). The reference PMID:36950384 is a large-scale protein interaction study where ELAVL3 may have been detected as an interactor, but this does not constitute evidence for "protein binding" as a molecular function. ELAVL3's primary molecular function is RNA binding, not protein binding.
Supporting Evidence:
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
Molecular Function: ELAVL3 binds preferentially to GU-rich and AU-rich sequences in intronic regions and 3'-untranslated regions (3'-UTRs) of target pre-mRNAs
PMID:36950384
eCollection 2023 Mar 8.
GO:0005515 protein binding
IPI
PMID:37207277
Using brain cell-type-specific protein interactomes to inter...
REMOVE
Summary: IPI annotation for protein binding based on physical interaction evidence from a large-scale brain cell-type-specific protein interactome study on schizophrenia.
Reason: Same rationale as for PMID:36950384. The generic "protein binding" term is uninformative and should be avoided in GO curation. While ELAVL3 does engage in protein-protein interactions, this is not its primary molecular function, and the term does not provide useful functional information. ELAVL3 is fundamentally an RNA-binding protein. Large-scale proteomics studies detect many interactions, but these do not necessarily represent the core molecular function of the protein.
Supporting Evidence:
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
Molecular Function: ELAVL3 binds preferentially to GU-rich and AU-rich sequences in intronic regions and 3'-untranslated regions (3'-UTRs) of target pre-mRNAs
PMID:37207277
eCollection 2023 May 19.
GO:0035925 mRNA 3'-UTR AU-rich region binding
IDA
PMID:10710437
RNA-binding analyses of HuC and HuD with the VEGF and c-myc ...
ACCEPT
Summary: IDA annotation for mRNA 3'-UTR AU-rich region binding based on direct experimental evidence from PMID:10710437. This is a duplicate of the IEA annotation but with stronger experimental evidence.
Reason: This is the gold standard annotation for ELAVL3 - direct experimental evidence (IDA) for its most specific and important molecular function. PMID:10710437 directly demonstrates using an ELISA-based assay that HuC (ELAVL3) binds to AU-rich elements in the 3'-UTRs of VEGF and c-myc mRNAs in a specific and concentration-dependent manner. This represents the core biochemical activity of ELAVL3. The experimental evidence is robust and the term is maximally informative.
Supporting Evidence:
PMID:10710437
I demonstrate that HuC and HuD bind to the VEGF 3'-UTR regulatory segment (VRS) and to the c- myc 3'-UTR in a specific and concentration-dependent pattern
PMID:10710437
These proteins bind to AU-rich elements in the 3'-untranslated regions (3'-UTRs) of many growth-related mRNAs, including c-myc and VEGF
GO:0005634 nucleus
NAS NEW
Summary: Added to align core_functions with existing annotations.
Reason: Core function term not present in existing_annotations. ELAVL3 has a smaller nuclear pool that supports roles in splicing and APA, consistent with nucleocytoplasmic shuttling driven by hinge-region signals.
Supporting Evidence:
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
ELAVL3 is involved in the development and maintenance of neurons. ELAVL3 binds over 1,100 transcripts in neuroendocrine cancer cell lines, with enrichment for genes involved in neuron projection development and synapse organization
UniProtKB:Q14576
May be involved in neuronal differentiation and maintenance (By similarity).
file:human/ELAVL3/ELAVL3-deep-research-falcon.md
ELAVL3 is predominantly cytoplasmic but capable of nucleocytoplasmic shuttling. A smaller nuclear pool supports roles in splicing and RNA processing, while the hinge/linker region contributes to export/localization control.
PMID:37697079
Nuclear export and localisation signals located in the hinge region of the ELAVL proteins are responsible for the shuttling of RNAs between the nucleus and cytoplasm
GO:0005737 cytoplasm
NAS NEW
Summary: Added to align core_functions with existing annotations.
Reason: Core function term not present in existing_annotations. nELAVL proteins including ELAVL3 are predominantly cytoplasmic where they participate in cytoplasmic mRNA stability and translation control.
Supporting Evidence:
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
ELAVL3 is involved in the development and maintenance of neurons. ELAVL3 binds over 1,100 transcripts in neuroendocrine cancer cell lines, with enrichment for genes involved in neuron projection development and synapse organization
UniProtKB:Q14576
May be involved in neuronal differentiation and maintenance (By similarity).
PMID:37697079
nELAVL proteins are primarily cytoplasmic, with a small fraction of nuclear activity, reflecting their roles (for example nuclear export, subcellular shuttling)
file:human/ELAVL3/ELAVL3-deep-research-falcon.md
ELAVL3 is predominantly cytoplasmic but capable of nucleocytoplasmic shuttling.
GO:0010608 post-transcriptional regulation of gene expression
NAS NEW
Summary: Added to align core_functions with existing annotations.
Reason: Core function term not present in existing_annotations. Falcon-cited literature reinforces ELAVL3's role as a post-transcriptional regulator controlling splicing, APA/3'-UTR length choice, mRNA stability and translation.
Supporting Evidence:
file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
ELAVL3 is involved in the development and maintenance of neurons. ELAVL3 binds over 1,100 transcripts in neuroendocrine cancer cell lines, with enrichment for genes involved in neuron projection development and synapse organization
UniProtKB:Q14576
May be involved in neuronal differentiation and maintenance (By similarity).
PMID:37697079
RNA-binding proteins (RBPs) are recognised as key regulators of post-transcriptional gene regulation, where their binding controls splicing, polyadenylation, nuclear export, mRNA stability and translation rate and decay
GO:0000380 alternative mRNA splicing, via spliceosome
NAS NEW
Summary: Added based on falcon-cited literature documenting ELAVL3 regulation of neuronal alternative splicing programs.
Reason: Falcon and Mulligan 2023 (PMID:37697079) document that ELAVL3 regulates alternative splicing of neuronal transcripts (e.g., AnkG/ANK3 exon 34) with convergence on glutamate-regulation and excitability pathways. This is a core molecular process not previously captured in existing_annotations.
Supporting Evidence:
PMID:37697079
Elavl3 regulates the embryonic-specific inclusion of vertebrate-specific exon 34 in the AnkG transcript.
PMID:37697079
High-throughput sequencing analysis of alternative splicing in the cerebellum of Elavl3βˆ’/βˆ’ mice highlighted the convergence of targeted transcripts on glutamate levels and neuronal excitability
file:human/ELAVL3/ELAVL3-deep-research-falcon.md
ELAVL3 has a documented role in alternative splicing; all three RRMs plus the hinge region contribute to HuC-dependent splice regulation, and ELAVL3 loss alters neuronal splicing programs linked to excitability.
GO:0110104 mRNA alternative polyadenylation
NAS NEW
Summary: Added based on falcon-cited literature documenting ELAVL3 regulation of alternative polyadenylation and 3'-UTR length choice in neurons.
Reason: Multiple sources cited by falcon (Mulligan 2023 PMID:37697079; Dorrity 2023 PMID:37862432) demonstrate that ELAVL3 (with other nELAVLs) promotes neuronal 3'-UTR lengthening through distal poly(A) site usage; ELAVL3 depletion shifts usage toward proximal sites. This is a distinct molecular process from splicing/stability and warrants a separate annotation.
Supporting Evidence:
PMID:37697079
Depletion of Elavl3 during this differentiation process caused a shift towards using proximal polyA sites compared to control cells, with a concomitant delay in neural stem cell differentiation
PMID:37862432
the neuron-enriched ELAVL family of genes (ELAVL2, ELAVL3, and ELAVL4) can increase (i) 3'UTR length, (ii) dsRNA load, and (iii) activation of dsRNA-sensing PRRs such as MDA5, PKR, and TLR3
file:human/ELAVL3/ELAVL3-deep-research-falcon.md
ELAVL3 participates in regulation of alternative polyadenylation and 3β€²UTR length in neurons. ELAVL3 depletion shifts usage toward proximal poly(A) sites, whereas neuronal ELAVL proteins promote longer neuronal 3β€²UTRs.
GO:0003729 mRNA binding
NAS NEW
Summary: Added to align core_functions with existing annotations.
Reason: Core function term not present in existing_annotations. ELAVL3 binds mRNA via three RRM domains; this captures the molecular function used to regulate splicing/APA/stability of target mRNAs.
Supporting Evidence:
PMID:37697079
All four ELAVL proteins share a common basic structure, of three RNA recognition motif (RRM) binding domains and a hinge region
PMID:37697079
Binding to RNA targets is facilitated by the RRM1 and RRM2 domains preferentially recognising AU-rich elements in the 3ΚΉUTR of transcripts

Core Functions

Binding to AU-rich and GU-rich elements in mRNA 3'-UTRs to stabilize target transcripts and regulate alternative splicing events in neurons

Supporting Evidence:
  • PMID:10710437
    With this assay, I demonstrate that HuC and HuD bind to the VEGF 3'-UTR regulatory segment (VRS) and to the c- myc 3'-UTR in a specific and concentration-dependent pattern, with both proteins showing a greater affinity for the VRS
  • file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
    ELAVL3 binds preferentially to GU-rich and AU-rich sequences in intronic regions and 3'-untranslated regions (3'-UTRs) of target pre-mRNAs. This binding regulates alternative splicing, mRNA stability, and transcript abundance
  • UniProtKB:Q14576
    RNA-binding protein that binds to AU-rich element (ARE) sequences of target mRNAs, including VEGF mRNA. Plays a role in the stabilization of GAP43 mRNA and in spatial learning

Regulating neuronal alternative splicing and alternative polyadenylation/3'-UTR length choice of target transcripts, including AnkG/ANK3 exon 34 and a broader program of glutamate-regulating and excitability-related transcripts

Supporting Evidence:
  • PMID:37697079
    Elavl3 regulates the embryonic-specific inclusion of vertebrate-specific exon 34 in the AnkG transcript.
  • PMID:37697079
    High-throughput sequencing analysis of alternative splicing in the cerebellum of Elavl3βˆ’/βˆ’ mice highlighted the convergence of targeted transcripts on glutamate levels and neuronal excitability
  • PMID:37862432
    the neuron-enriched ELAVL family of genes (ELAVL2, ELAVL3, and ELAVL4) can increase (i) 3'UTR length, (ii) dsRNA load, and (iii) activation of dsRNA-sensing PRRs such as MDA5, PKR, and TLR3
  • file:human/ELAVL3/ELAVL3-deep-research-falcon.md
    ELAVL3 has a documented role in alternative splicing; all three RRMs plus the hinge region contribute to HuC-dependent splice regulation, and ELAVL3 loss alters neuronal splicing programs linked to excitability.

Adapting AU-rich mRNA transcripts to post-transcriptional regulatory complexes to control neuronal gene expression programs

Supporting Evidence:
  • file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
    ELAVL3 is involved in the development and maintenance of neurons. ELAVL3 binds over 1,100 transcripts in neuroendocrine cancer cell lines, with enrichment for genes involved in neuron projection development and synapse organization
  • UniProtKB:Q14576
    May be involved in neuronal differentiation and maintenance. Plays a role in the stabilization of GAP43 mRNA

References

Gene Ontology annotation through association of InterPro records with GO terms.
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara.
Electronic Gene Ontology annotations created by ARBA machine learning models
Combined Automated Annotation using Multiple IEA Methods.
RNA-binding analyses of HuC and HuD with the VEGF and c-myc 3'-untranslated regions using a novel ELISA-based assay.
Protein interaction studies in human induced neurons indicate convergent biology underlying autism spectrum disorders.
Using brain cell-type-specific protein interactomes to interpret neurodevelopmental genetic signals in schizophrenia.
The molecular genetics of nELAVL in brain development and disease.
  • ELAVL3 is the only nELAVL expressed in Purkinje neurons; Elavl3 knockout mice develop progressive cerebellar ataxia with disrupted Purkinje synaptic formation, swollen axons, and neuronal transport deficits, and Elavl3+/- and -/- mice show seizure activity.
    "As Elavl3βˆ’/βˆ’ mice aged, progressive severe cerebellar ataxia was observed. This ataxia caused an abnormal step cycle, tremor and over time, impaired postural reflexes. At the cellular level, Purkinje neurons had disrupted synaptic formation, swollen axons, and overall deficits in neuronal transport, highlighting the requirement for Elavl3 activity in these neurons"
  • ELAVL3 regulates alternative splicing of neuronal transcripts converging on glutamate regulation and excitability, including embryonic-specific inclusion of AnkG exon 34; ELAVL3 also drives 3'-UTR lengthening via distal poly(A) site usage during inhibitory neuron differentiation.
    "High-throughput sequencing analysis of alternative splicing in the cerebellum of Elavl3βˆ’/βˆ’ mice highlighted the convergence of targeted transcripts on glutamate levels and neuronal excitabilityβ€”linking RNA regulation to the seizure activity observed in Elavl3βˆ’/βˆ’ mice"
  • All four ELAVL proteins share three RNA recognition motifs (RRMs) with a hinge region; RRM1 and RRM2 directly bind AU-rich elements in 3'-UTRs, while RRM3 supports transcript stability via poly(A)-associated mechanisms.
    "Binding to RNA targets is facilitated by the RRM1 and RRM2 domains preferentially recognising AU-rich elements in the 3ΚΉUTR of transcripts"
Long 3'UTRs predispose neurons to inflammation by promoting immunostimulatory double-stranded RNA formation.
  • The neuron-enriched ELAVL family (ELAVL2, ELAVL3, ELAVL4) collectively drives 3'-UTR lengthening in human neurons, which in turn raises dsRNA load and tonically activates dsRNA-sensing PRRs (MDA5, PKR, TLR3).
    "the neuron-enriched ELAVL family of genes (ELAVL2, ELAVL3, and ELAVL4) can increase (i) 3'UTR length, (ii) dsRNA load, and (iii) activation of dsRNA-sensing PRRs such as MDA5, PKR, and TLR3"
High-resolution epitope mapping of anti-Hu and anti-Yo autoimmunity by programmable phage display.
  • ELAVL3/HuC is one of the neuronal ELAVL (nELAVL) proteins targeted by anti-Hu paraneoplastic autoantibodies; the dominant immunodominant epitope maps to a 17-residue motif in the hinge region between RRM2 and RRM3 shared across ELAVL2/3/4, with most enriched peptides (>80%) attributed to ELAVL4.
    "A majority (>90%) of the significantly enriched nELAVL peptides converged upon on a 17-residue sequence at AA positions 276–294 of ELAVL4, a sequence which is also common to variants of ELAVL2 and ELAVL3"
ELAV/Hu RNA-binding protein family - key regulators in neurological disorders, cancer, and other diseases.
  • ELAVL3 is restricted to the nervous system, essential for cerebellar function, and involved in neuronal differentiation and excitability; ELAVL3 dysregulation is associated with epilepsy.
    "Both Elavl3 and Elavl4 are restricted to the nervous system and are involved in neuronal differentiation and excitability. Elavl3 is essential for cerebellar function and has been associated with epilepsy"
file:human/ELAVL3/ELAVL3-deep-research-falcon.md
Falcon (Edison Scientific Literature) deep research report: ELAVL3 (HuC) functional annotation
  • ELAVL3 functions as a post-transcriptional regulator that uses three RRMs plus a hinge region to bind AU-/U-rich elements in 3'-UTRs, with RRM3 contributing poly(A)-tail binding; functions span splicing, APA/3'-UTR length, mRNA stability, and translation. ELAVL3 is predominantly cytoplasmic with nucleocytoplasmic shuttling.
    "ELAVL3 functions primarily as a post-transcriptional regulator that stabilizes target transcripts, in part by binding AU-rich elements and influencing poly(A)-tail-associated protection; ELAVL proteins can multimerize on RNA and oppose destabilizing factors."
  • ELAVL3 has a documented role in alternative splicing in which all three RRMs plus the hinge region contribute to HuC-dependent splice regulation; ELAVL3 loss alters neuronal splicing programs linked to excitability.
    "ELAVL3 has a documented role in alternative splicing; all three RRMs plus the hinge region contribute to HuC-dependent splice regulation, and ELAVL3 loss alters neuronal splicing programs linked to excitability."
  • ELAVL3 participates in alternative polyadenylation control of neuronal 3'-UTR length; ELAVL3 depletion shifts poly(A) usage toward proximal sites.
    "ELAVL3 participates in regulation of alternative polyadenylation and 3β€²UTR length in neurons. ELAVL3 depletion shifts usage toward proximal poly(A) sites, whereas neuronal ELAVL proteins promote longer neuronal 3β€²UTRs."

Deep Research

Falcon

(ELAVL3-deep-research-falcon.md)
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate. Falcon Edison Scientific Literature 22 citations 4 artifacts 2026-05-29T17:59:56.186302

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Research report: ELAVL3 (HuC) functional annotation (Human; UniProt Q14576)

Scope and identity verification

The target of this report is human ELAVL3 (UniProt Q14576), encoding ELAV-like protein 3, historically named HuC, a neuron-enriched member of the neuronal ELAVL (nELAVL) RNA-binding protein family (ELAVL2/HuB, ELAVL3/HuC, ELAVL4/HuD), distinct from the ubiquitously expressed ELAVL1/HuR. This identity mapping (ELAVL3β†’HuC) is explicitly stated in a recent authoritative genetics review of nELAVLs. (mulligan2023themoleculargenetics pages 1-2, mulligan2023themoleculargenetics pages 2-4)

Property Summary for ELAVL3 (HuC; UniProt Q14576) Supporting citations
Approved gene / protein name ELAVL3 encodes ELAV-like protein 3, a neuronal RNA-binding protein in human. Historical name HuC is explicitly mapped to ELAVL3 in review literature. (mulligan2023themoleculargenetics pages 2-4, mulligan2023themoleculargenetics pages 1-2)
Synonyms / aliases Common aliases include HuC; the UniProt-provided aliases for this target are HUC and PLE21. Literature in the retrieved evidence directly confirms the HuC name for ELAVL3. (mulligan2023themoleculargenetics pages 1-2)
Organism / target identity The reviewed literature matches the intended target: human ELAVL3/HuC, a neuronal ELAVL-family RNA-binding protein, with no conflicting gene identity found in the evidence set. (mulligan2023themoleculargenetics pages 2-4, mulligan2023themoleculargenetics pages 1-2)
Family membership ELAVL3 belongs to the neuronal ELAVL (nELAVL) subgroup together with ELAVL2/HuB and ELAVL4/HuD; ELAVL1/HuR is the ubiquitous family member. nELAVLs are enriched in the nervous system. (mulligan2023themoleculargenetics pages 2-4, mulligan2023themoleculargenetics pages 1-2, negeri2024theroleof pages 39-45, medici2026targetingtherna pages 8-12)
Domain architecture ELAVL3 shares the canonical ELAVL architecture of three RNA recognition motifs (RRM1, RRM2, RRM3) plus a hinge/linker region between RRM2 and RRM3. The hinge contributes to protein interactions and nucleocytoplasmic trafficking. (mulligan2023themoleculargenetics pages 2-4, mulligan2023themoleculargenetics pages 7-8, costantino2024elavl3disruptionina pages 22-26, costantino2024elavl3disruptionin pages 22-26)
RNA-binding specificity ELAVL proteins, including ELAVL3, preferentially bind AU-/U-rich elements in target RNAs, especially in 3β€²UTRs. RRM1/2 mediate direct binding to AU-rich RNA, whereas RRM3 contributes to poly(A)-tail binding and transcript stabilization. (medici2026targetingtherna pages 8-12, mulligan2023themoleculargenetics pages 2-4, mulligan2023themoleculargenetics pages 7-8, costantino2024elavl3disruptionina pages 22-26)
Core molecular function: mRNA stability ELAVL3 functions primarily as a post-transcriptional regulator that stabilizes target transcripts, in part by binding AU-rich elements and influencing poly(A)-tail-associated protection; ELAVL proteins can multimerize on RNA and oppose destabilizing factors. (negeri2024theroleof pages 39-45, mulligan2023themoleculargenetics pages 2-4, costantino2024elavl3disruptionina pages 22-26)
Core molecular function: translation ELAVL-family proteins regulate translation as part of ribonucleoprotein complexes that route RNAs toward translation or decay; RRM3/poly(A)-associated functions connect ELAVL3 to translational control. (negeri2024theroleof pages 39-45, mulligan2023themoleculargenetics pages 2-4, costantino2024elavl3disruptionina pages 22-26)
Core molecular function: alternative splicing ELAVL3 has a documented role in alternative splicing; all three RRMs plus the hinge region contribute to HuC-dependent splice regulation, and ELAVL3 loss alters neuronal splicing programs linked to excitability. (mulligan2023themoleculargenetics pages 7-8, mulligan2023themoleculargenetics pages 6-7, costantino2024elavl3disruptionin pages 22-26)
Core molecular function: alternative polyadenylation / 3β€²UTR length ELAVL3 participates in regulation of alternative polyadenylation and 3β€²UTR length in neurons. ELAVL3 depletion shifts usage toward proximal poly(A) sites, whereas neuronal ELAVL proteins promote longer neuronal 3β€²UTRs. (mulligan2023themoleculargenetics pages 6-7, dorrity2023long3β€²utrspredispose pages 8-9)
Biological role emphasis Current understanding places ELAVL3 as a key neuronal post-transcriptional regulator affecting transcript isoform choice, mRNA stability, neuronal differentiation, glutamate-related pathways, and neuronal excitability. (mulligan2023themoleculargenetics pages 2-4, mulligan2023themoleculargenetics pages 6-7, wutikeli2025elavhurnabindingprotein pages 6-7)
Typical subcellular localization ELAVL3 is predominantly cytoplasmic but capable of nucleocytoplasmic shuttling. A smaller nuclear pool supports roles in splicing and RNA processing, while the hinge/linker region contributes to export/localization control. (negeri2024theroleof pages 39-45, mulligan2023themoleculargenetics pages 2-4, mulligan2023themoleculargenetics pages 4-5, costantino2024elavl3disruptionin pages 22-26)

Table: This table summarizes the verified identity, family context, domain organization, RNA-binding specificity, molecular functions, and localization of human ELAVL3/HuC. It is useful as a concise reference for functional annotation grounded in the retrieved evidence.

1) Key concepts and definitions (current understanding)

ELAVL3/HuC as a neuronal RNA-binding protein (RBP)

ELAVL3 is best understood as a post-transcriptional regulator that binds mRNAs to control their processing and fate, including alternative splicing, alternative polyadenylation (APA)/3β€²UTR length choice, mRNA stability/decay, mRNA transport, and translation. This β€œmulti-layer” control is a canonical feature of ELAVL family RBPs in neuronal programs. (mulligan2023themoleculargenetics pages 2-4, negeri2024theroleof pages 39-45)

Domain architecture and RNA-binding specificity

Across ELAVL proteins, a conserved architecture of three RNA recognition motifs (RRM1–RRM3) plus a hinge/linker region supports RNA binding and nucleo-cytoplasmic dynamics. Mechanistically, RRM1/2 primarily mediate binding to AU-/U-rich elements commonly found in 3β€²UTRs, while RRM3 contributes to binding at/near the poly(A) tail and transcript stabilization; ELAVL proteins can also multimerize on RNA in an RNA-dependent manner to enhance binding. HuC’s three RRMs and hinge region have distinct roles in alternative splicing regulation, indicating domain specialization within this architecture. (mulligan2023themoleculargenetics pages 2-4, medici2026targetingtherna pages 8-12, costantino2024elavl3disruptionina pages 22-26, mulligan2023themoleculargenetics pages 7-8)

Subcellular localization and site of action

nELAVLs (including ELAVL3) are described as predominantly cytoplasmic while retaining the ability to shuttle between nucleus and cytoplasm, consistent with combined functions in nuclear pre-mRNA processing (e.g., splicing/APA decisions) and cytoplasmic control of mRNA stability/translation. (negeri2024theroleof pages 39-45, mulligan2023themoleculargenetics pages 2-4, costantino2024elavl3disruptionin pages 22-26)

2) Recent developments and latest research (prioritizing 2023–2024)

Publication Date Venue URL / DOI Study type Key ELAVL3/HuC findings Quantitative data Supporting citations
Mulligan, 2023 Sep 2023 European Journal of Human Genetics https://doi.org/10.1038/s41431-023-01456-z Review; human/mouse/genetics Authoritative review confirming human ELAVL3 = HuC; neuronal ELAVL family member with 3 RRMs + hinge; regulates mRNA stability, translation, alternative splicing, and alternative polyadenylation/3β€²UTR length; ELAVL3 loss linked to altered glutamate-regulatory transcripts, neuronal excitability, delayed GABAergic differentiation, seizures, and cerebellar ataxia. Also summarizes ALS-linked nuclear depletion/downregulation and proposes biomarker relevance. Notes ELAVL3-dependent AnkG exon 34 mis-splicing at 2 and 9 months in knockout mice; cites large human genetics datasets including >16,000 ASD GWAS individuals, 2,104 ID trios, and 42,607 autism cases in broader ELAVL-family analyses. (mulligan2023themoleculargenetics pages 2-4, mulligan2023themoleculargenetics pages 1-2, mulligan2023themoleculargenetics pages 6-7, mulligan2023themoleculargenetics pages 7-8, mulligan2023themoleculargenetics pages 5-6)
Dorrity, 2023 Oct 2023 Science Immunology https://doi.org/10.1126/sciimmunol.adg2979 Primary; human stem cell-derived neurons and cell systems Shows neuron-enriched ELAVL proteins (ELAVL2/3/4) promote neuronal 3β€²UTR lengthening, increasing dsRNA load and tonic activation of dsRNA sensors (MDA5, PKR, TLR3). HuC is implicated in a neuron-specific post-transcriptional program that couples long 3β€²UTRs to antiviral immunity and inflammatory risk. Combined HuB/C/D expression caused global 3β€²UTR lengthening without major bulk transcript-level changes. Reports that more than half of human genes have alternative 3β€²UTRs; human developmental atlas integrated 393,060 single cells is cited elsewhere as context for developmental expression; ADAR1 KO neurons died by day 25 after differentiation in this study. (dorrity2023long3β€²utrspredispose pages 8-9)
O’Donovan, 2020 Jul 2020 Brain Communications https://doi.org/10.1093/braincomms/fcaa059 Primary; human serum/CSF, paraneoplastic neurology Closest highly relevant clinical paper for anti-Hu autoimmunity. Anti-Hu antibodies target the neuronal ELAVL family including ELAVL3/HuC, but dominant mapped reactivity centered on a shared nELAVL epitope motif rather than uniquely on ELAVL3. High-resolution PhIP-Seq/mutational scanning identified an immunodominant RLDxLL motif and a focused 17-residue signature near the ELAVL hinge region, supporting diagnostic epitope mapping applications. Cohorts: 44 anti-Hu patients and 36 anti-Yo patients; 38% of anti-Hu patients enriched nELAVL peptides; 76 total anti-Hu samples (32 paired serum/CSF, 2 CSF, 10 serum); 19 samples with significant nELAVL enrichment; 20 unique nELAVL peptides; >80% of enriched peptides mapped to ELAVL4; 0/50 healthy control sera showed significant nELAVL enrichment; 34/36 (94%) peptides in motif reanalysis shared RLDxxLL. (o’donovan2020highresolutionepitopemapping pages 2-3, o’donovan2020highresolutionepitopemapping pages 13-13, o’donovan2020highresolutionepitopemapping pages 10-10, o’donovan2020highresolutionepitopemapping pages 1-2, o’donovan2020highresolutionepitopemapping pages 13-14, o’donovan2020highresolutionepitopemapping pages 12-13, o’donovan2020highresolutionepitopemapping media bbad15e1, o’donovan2020highresolutionepitopemapping media f77dc5fb)
Kim, 2024 Oct 2024 Experimental & Molecular Medicine https://doi.org/10.1038/s12276-024-01328-6 Primary; human single-cell atlas / developmental expression Integrative single-cell atlas of developing human brain includes ELAVL3 among disorder-related genes with temporally patterned neuronal expression, supporting its role as a neuronal lineage/development marker and neurodevelopmental risk-associated gene. Atlas integrates 393,060 single cells across developmental stages. (dorrity2023long3β€²utrspredispose pages 8-9)
Costantino, 2024 2024 Dissertation / neuropathology study DOI not clearly resolved in evidence excerpt Primary; human postmortem ALS/FTLD tissue Focused 2024 human neuropathology study of ELAVL3 disruption in ALS/FTLD. Reports cryptic mis-splicing of ELAVL3 transcripts, nuclear depletion of ELAVL3 protein, cytoplasmic granular pathology, and ELAVL3-positive threadlike processes. Reduced nuclear ELAVL3 associates with pTDP-43 or tau pathology, suggesting shared RNA-binding protein dysfunction across neurodegenerative proteinopathies. In prior anterior horn motor neurons, nearly 75% showed total loss of nuclear ELAVL3; in FTLD-Tau, 4/5 cases showed related ELAVL3 nuclear loss in cells with phosphorylated aggregates. (costantino2024elavl3disruptioninb pages 107-112, costantino2024elavl3disruptionina pages 107-112, costantino2024elavl3disruptionina pages 1-7)
Moakley, 2024 Jun 2024 bioRxiv https://doi.org/10.1101/2024.06.13.597128 Primary preprint; mouse single-cell/splicing network Reverse-engineering study of neuron type-specific splicing networks identifies Elavl3/HuC as broadly expressed among neuronal classes and part of splicing-regulatory programs shaping neuronal identity. Useful for pathway context, though not an ELAVL3-focused mechanistic paper. Derived networks from 133 mouse neocortical cell types defined by single-cell transcriptomes and inferred regulons for 350 RBPs. (OpenTargets Search: -ELAVL3)
Lee, 2023 Oct 2023 Life Science Alliance https://doi.org/10.26508/lsa.202302000 Review; neuronal RNA processing Broad review of neuronal alternative splicing and polyadenylation that provides pathway context for nELAVL proteins, including ELAVL3, as regulators of neural-specific isoform processing and 3β€²UTR biology. No ELAVL3-specific quantitative value extracted from available excerpt. (OpenTargets Search: -ELAVL3)
Lee, 2024 Jun 2024 Experimental & Molecular Medicine https://doi.org/10.1038/s12276-024-01177-3 Review; human transcriptome / RNA regulation Review of inverted Alu repeats notes neuron-enriched ELAVL2/3/4 in the context of RNA structure and post-transcriptional control, relevant to ELAVL3’s role in neuronal transcriptome regulation and dsRNA-linked processes. No ELAVL3-specific quantitative value extracted from available excerpt. (OpenTargets Search: -ELAVL3)

Table: This table compiles the main 2023-2024 and closest relevant studies in the evidence set that mention ELAVL3/HuC, emphasizing function, disease relevance, and quantitative findings. It is useful as a quick reference for prioritizing the strongest sources for functional annotation and clinical context.

ELAVL3 in neuronal alternative splicing programs linked to excitability

A 2023 synthesis of molecular genetics evidence highlights that ELAVL3 loss perturbs alternative splicing programs converging on glutamate regulation and neuronal excitability; for example, ELAVL3 regulates developmental splicing of a vertebrate-specific exon in ANK3/AnkyrinG (AnkG exon 34), where knockout animals show inappropriate exon inclusion at later ages (reported at 2 and 9 months) and human RNA-seq supports canonical exon exclusion in human prefrontal cortex. These findings connect ELAVL3’s molecular splicing control to circuit-level phenotypes such as seizures/ataxia observed in model systems. (mulligan2023themoleculargenetics pages 6-7)

ELAVL3 and alternative polyadenylation / 3β€²UTR length

Multiple lines of evidence link neuronal ELAVL proteins to APA and neuronal 3β€²UTR lengthening. During differentiation toward inhibitory neuronal fates, ELAVL3 expression increases alongside 3β€²UTR lengthening, and ELAVL3 depletion shifts poly(A) usage toward proximal sites and delays differentiation. (mulligan2023themoleculargenetics pages 6-7)

A 2023 Science Immunology study provided a mechanistic framework in human cellular systems: co-expression of neuron-enriched ELAVL proteins (HuB/HuC/HuD; ELAVL2/3/4) can produce global 3β€²UTR lengthening (isoform switching without major changes in total transcript abundance), which increases the formation of immunostimulatory dsRNA structures and engages dsRNA sensors (MDA5, PKR, TLR3). This work places ELAVL-family-mediated 3β€²UTR regulation upstream of innate immune tone in neurons and provides an emerging functional link between neuronal post-transcriptional programs and neuroinflammatory risk. (dorrity2023long3β€²utrspredispose pages 8-9)

A recent review of ELAV/Hu proteins notes CLIP-based evidence that ELAVL3 binds U-rich regions in glutamine synthetase mRNA and highlights connections to glutamate-network regulation and electrical activity. While this is review-level synthesis (and not 2023–2024), it provides a pathway-level interpretation consistent with the 2023 genetics review emphasis on excitability/glutamate-related targets. (wutikeli2025elavhurnabindingprotein pages 6-7, mulligan2023themoleculargenetics pages 6-7)

3) Current applications and real-world implementations

Diagnostic relevance in paraneoplastic anti-Hu autoimmunity

ELAVL3/HuC is one of the neuronal ELAVL proteins that constitute the anti-Hu (nELAVL) autoantigen family in paraneoplastic neurological disorders. A proteome-wide programmable phage display (PhIP-seq) study of anti-Hu patients demonstrates real-world translational use of epitope mapping for diagnosis/biomarker characterization, identifying a focused signature and an immunodominant motif shared across nELAVLs. (o’donovan2020highresolutionepitopemapping pages 1-2, o’donovan2020highresolutionepitopemapping pages 2-3)

Key cohort-level statistics from this study include: anti-Hu cohort n=44, with 38% showing enrichment for nELAVL peptides; anti-Yo comparator cohort n=36; and 0/50 healthy control sera showing significant nELAVL peptide enrichment in this assay. (o’donovan2020highresolutionepitopemapping pages 1-2, o’donovan2020highresolutionepitopemapping pages 10-10)

The epitope-level resolution is supported by figure evidence showing cohort mapping and the sequence-logo motif: (o’donovan2020highresolutionepitopemapping media bbad15e1, o’donovan2020highresolutionepitopemapping media f77dc5fb)

Neuropathology/biomarker work in neurodegeneration (ALS/FTLD)

A 2024 human neuropathology-focused work reports nuclear depletion of ELAVL3 in ALS/FTLD-spectrum disease tissue, including a prior finding that nearly 75% of anterior horn motor neurons showed total loss of nuclear ELAVL3. In cortex, reduced nuclear ELAVL3 is associated with cells containing phosphorylated aggregates (TDP-43 or tau), with overlap in FTLD-tau cases (majority 4/5 showing related ELAVL3 nuclear loss in cells with phosphorylated aggregates). These observations motivate ELAVL3 immunostaining/localization as a practical research readout and candidate biomarker feature across proteinopathies. (costantino2024elavl3disruptionina pages 107-112, costantino2024elavl3disruptioninb pages 107-112)

4) Expert opinions and analysis (authoritative interpretations)

A 2023 European Journal of Human Genetics review frames nELAVL proteins (including ELAVL3/HuC) as central organizers of neuronal post-transcriptional programs across developmental windows, emphasizing the integration of splicing, APA/3β€²UTR length, and mRNA stability/translation in shaping neuronal identity and function. This review also highlights that ELAVL-related pathology shares a neurological theme but with phenotype specificity across paralogs, consistent with their spatiotemporal expression differences. (mulligan2023themoleculargenetics pages 2-4, mulligan2023themoleculargenetics pages 6-7)

The 2023 Science Immunology study provides an expert-level mechanistic reframing: neuron-specific post-transcriptional choices (e.g., longer 3β€²UTRs) are not only developmental/regulatory features but can become immunostimulatory substrates (dsRNA) that set baseline antiviral signaling and potentially contribute to toxic inflammation if dysregulated (e.g., in ADAR1 deficiency). This suggests ELAVL-family RBPs may influence neuroinflammation risk indirectly through transcript architecture rather than classical cytokine pathways. (dorrity2023long3β€²utrspredispose pages 8-9)

5) Relevant statistics and data (recent studies)

Context Finding Quantitative/statistics Application/implementation Supporting citation IDs
Paraneoplastic anti-Hu autoimmunity cohort Anti-Hu paraneoplastic neurological disorder sera/CSF show reactivity to neuronal ELAVL proteins (including ELAVL3/HuC), but the dominant mapped response in this dataset is concentrated on shared nELAVL epitopes and is largely ELAVL4-biased rather than ELAVL3-specific. Anti-Hu cohort n=44; anti-Yo comparator n=36; 38% of anti-Hu patients enriched nELAVL peptides; 76 anti-Hu samples total (32 paired serum/CSF, 2 CSF, 10 serum); 19 samples with significant nELAVL enrichment; 20 unique nELAVL peptides; >80% of enriched peptides mapped to ELAVL4; 0/50 healthy control sera showed significant nELAVL enrichment. Supports laboratory use of PhIP-Seq/high-resolution epitope mapping for paraneoplastic antibody characterization and differential diagnosis; high control specificity in this dataset supports translational diagnostic value. (o’donovan2020highresolutionepitopemapping pages 2-3, o’donovan2020highresolutionepitopemapping pages 10-10, o’donovan2020highresolutionepitopemapping pages 1-2)
Anti-Hu epitope definition The immunodominant anti-Hu/nELAVL antibody signature maps to a short region near the exon 6/7a junction and centers on a recurring motif shared across nELAVL proteins, including ELAVL3. Dominant 17-residue signature; deep mutational scanning identified a preferred RLDxLL motif; 34/36 (94%) significant peptides in motif reanalysis shared RLDxxLL. Enables epitope-level assay design, mechanistic interpretation of anti-Hu serology, and refined antigen mapping beyond whole-protein tests. (o’donovan2020highresolutionepitopemapping pages 2-3, o’donovan2020highresolutionepitopemapping pages 13-13, o’donovan2020highresolutionepitopemapping pages 13-14, o’donovan2020highresolutionepitopemapping media bbad15e1, o’donovan2020highresolutionepitopemapping media f77dc5fb)
Central tolerance / antigenicity context The anti-Hu signature region is linked to thymic exon exclusion and predicted MHC-I presentation, consistent with a mechanism for autoreactivity against nELAVL proteins. In human thymic epithelial cell amplicon sequencing, exon 7a-containing reads were <0.5%; human TEC libraries averaged ~1 million 125-nt paired-end reads each, in triplicate. Relevant to mechanistic interpretation of paraneoplastic autoimmunity and may guide future biomarker/epitope validation studies. (o’donovan2020highresolutionepitopemapping pages 13-13, o’donovan2020highresolutionepitopemapping pages 13-14)
ALS/FTLD neuropathology Human neurodegenerative disease tissue shows ELAVL3/HuC nuclear depletion and abnormal cytoplasmic pathology, supporting ELAVL3 disruption as a neuropathological marker in ALS/FTLD-spectrum disease. Prior anterior horn motor neuron study: nearly 75% of neurons showed total loss of nuclear ELAVL3. Potential neuropathology biomarker and disease-stratification feature in ALS/FTLD research workflows; supports ELAVL3 immunostaining as a readout of RNA-binding protein dysfunction. (costantino2024elavl3disruptioninb pages 107-112, costantino2024elavl3disruptionina pages 107-112, mulligan2023themoleculargenetics pages 5-6)
FTLD-Tau overlap ELAVL3 nuclear loss is not restricted to TDP-43 proteinopathy and also appears in tauopathy-associated FTLD cells with phosphorylated aggregates. Majority of FTLD-Tau cases 4/5 showed related ELAVL3 nuclear loss in cells with phosphorylated aggregates. Suggests ELAVL3 depletion may be a shared marker across proteinopathies, broadening relevance beyond classic TDP-43 ALS/FTLD. (costantino2024elavl3disruptioninb pages 107-112, costantino2024elavl3disruptionina pages 107-112)
Human ALS model relevance ELAVL3 abnormalities may occur early in disease-linked cellular models and have been proposed as earlier or complementary markers relative to TDP-43 abnormalities. Review-level summary indicates ELAVL3 abnormalities were reported as more common/earlier than TDP-43 abnormalities in cited patient/model studies, but no explicit n or effect size was provided in the extracted text. Supports investigation of ELAVL3 as an early biomarker or therapeutic focus in ALS research, though quantitative validation is still needed. (mulligan2023themoleculargenetics pages 5-6)
Open Targets disease association ELAVL3 has curated disease-target associations in Open Targets spanning neurodevelopmental and neurologic phenotypes. Neurodegenerative disease score 0.4831; Cannabis use 0.1452; generalised epilepsy 0.0978; autism spectrum disorder 0.0924; generalized epilepsy with febrile seizures-plus 0.0874; evidence count 5 for each listed disease in the retrieved summary. Useful for target prioritization, disease landscaping, and hypothesis generation; these are association scores, not proof of causality. (OpenTargets Search: -ELAVL3)

Table: This table summarizes clinically relevant ELAVL3/HuC evidence from the retrieved literature and databases, including anti-Hu paraneoplastic autoimmunity metrics, neuropathology findings in ALS/FTLD, and Open Targets disease associations. It is useful for connecting molecular annotation to diagnostic and translational contexts.

Additional notable quantitative points include:
- In anti-Hu PhIP-seq epitope mapping, the immunodominant motif was highly recurrent: 34/36 (94%) significant peptides shared an RLDxxLL core, supporting a dominant motif-level signature across enriched peptides. (o’donovan2020highresolutionepitopemapping pages 13-13)
- Thymic epithelial cell sequencing found exon 7a-containing reads at <0.5%, offering a quantitative clue about central tolerance mechanisms for the anti-Hu signature region. (o’donovan2020highresolutionepitopemapping pages 13-14)
- A 2024 integrative single-cell atlas of developing human brain compiled 393,060 single cells, providing modern context for neuronal lineage markers and disorder-gene temporal specificity (including ELAVL3). (OpenTargets Search: -ELAVL3)

Pathways and biological processes most supported by current evidence

Neuronal differentiation and maturation

ELAVL3 expression and function are tied to neuronal differentiation programs, including inhibitory neuron differentiation in model systems, where ELAVL3 depletion delays differentiation and shifts APA toward proximal sites. (mulligan2023themoleculargenetics pages 6-7)

Neuronal excitability and glutamate homeostasis

Genetic and molecular data converge on ELAVL3-dependent regulation of transcripts linked to glutamate regulation and neuronal excitability, consistent with seizure phenotypes in loss-of-function contexts and with CLIP-based linking to glutamine synthetase mRNA described in review synthesis. (mulligan2023themoleculargenetics pages 6-7, wutikeli2025elavhurnabindingprotein pages 6-7)

RNA-architecture-dependent innate immune signaling

Neuron-enriched ELAVL proteins (including HuC/ELAVL3) can drive longer 3β€²UTRs and increased dsRNA structures that activate dsRNA-sensing PRRs (MDA5, PKR, TLR3), tying ELAVL-family activity to innate immune tone and vulnerability/resilience to neurotropic viral infection or toxic inflammation under editing defects. (dorrity2023long3β€²utrspredispose pages 8-9)

Limitations of the current evidence set

Although ELAVL3 is well supported as an RBP controlling splicing/APA/stability and linked to excitability and disease phenotypes, the retrieved 2023–2024 primary literature in this run provides limited direct, ELAVL3-only quantitative biochemistry (e.g., binding affinities, target lists) compared with the broader nELAVL family; several mechanistic target statements are presented via reviews. (mulligan2023themoleculargenetics pages 6-7, wutikeli2025elavhurnabindingprotein pages 6-7)

Key URLs (with publication timing from retrieved sources)

  • Mulligan & Bicknell. Eur J Hum Genet. Sep 2023. https://doi.org/10.1038/s41431-023-01456-z (mulligan2023themoleculargenetics pages 2-4, mulligan2023themoleculargenetics pages 1-2)
  • Dorrity et al. Science Immunology. Oct 2023. https://doi.org/10.1126/sciimmunol.adg2979 (dorrity2023long3β€²utrspredispose pages 8-9)
  • Kim et al. Experimental & Molecular Medicine. Oct 2024. https://doi.org/10.1038/s12276-024-01328-6 (OpenTargets Search: -ELAVL3)
  • O’Donovan et al. Brain Communications. Jul 2020. https://doi.org/10.1093/braincomms/fcaa059 (o’donovan2020highresolutionepitopemapping pages 1-2, o’donovan2020highresolutionepitopemapping pages 2-3)
  • Open Targets ELAVL3 disease associations (platform). Evidence summarized in retrieved OpenTargets output. https://platform.opentargets.org/target/ENSG00000196361 (OpenTargets Search: -ELAVL3)

References

  1. (mulligan2023themoleculargenetics pages 1-2): Meghan R. Mulligan and Louise S. Bicknell. The molecular genetics of nelavl in brain development and disease. European Journal of Human Genetics, 31:1209-1217, Sep 2023. URL: https://doi.org/10.1038/s41431-023-01456-z, doi:10.1038/s41431-023-01456-z. This article has 54 citations and is from a domain leading peer-reviewed journal.

  2. (mulligan2023themoleculargenetics pages 2-4): Meghan R. Mulligan and Louise S. Bicknell. The molecular genetics of nelavl in brain development and disease. European Journal of Human Genetics, 31:1209-1217, Sep 2023. URL: https://doi.org/10.1038/s41431-023-01456-z, doi:10.1038/s41431-023-01456-z. This article has 54 citations and is from a domain leading peer-reviewed journal.

  3. (negeri2024theroleof pages 39-45): Olanta Negeri. The role of the elavl family of rna-binding proteins in lrrk2-dependent models of parkinson's disease. Text, Feb 2024. URL: https://doi.org/10.20381/ruor-30139, doi:10.20381/ruor-30139. This article has 0 citations and is from a peer-reviewed journal.

  4. (medici2026targetingtherna pages 8-12): M Medici. Targeting the rna binding protein hud to control als disease. Unknown journal, 2026.

  5. (mulligan2023themoleculargenetics pages 7-8): Meghan R. Mulligan and Louise S. Bicknell. The molecular genetics of nelavl in brain development and disease. European Journal of Human Genetics, 31:1209-1217, Sep 2023. URL: https://doi.org/10.1038/s41431-023-01456-z, doi:10.1038/s41431-023-01456-z. This article has 54 citations and is from a domain leading peer-reviewed journal.

  6. (costantino2024elavl3disruptionina pages 22-26): I Costantino. Elavl3 disruption in amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a neuropathological view. Unknown journal, 2024.

  7. (costantino2024elavl3disruptionin pages 22-26): I Costantino. Elavl3 disruption in amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a neuropathological view. Unknown journal, 2024.

  8. (mulligan2023themoleculargenetics pages 6-7): Meghan R. Mulligan and Louise S. Bicknell. The molecular genetics of nelavl in brain development and disease. European Journal of Human Genetics, 31:1209-1217, Sep 2023. URL: https://doi.org/10.1038/s41431-023-01456-z, doi:10.1038/s41431-023-01456-z. This article has 54 citations and is from a domain leading peer-reviewed journal.

  9. (dorrity2023long3β€²utrspredispose pages 8-9): Tyler J. Dorrity, Heegwon Shin, Kenenni A. Wiegand, Justin Aruda, Michael Closser, Emily Jung, Jake A. Gertie, Amanda Leone, Rachel Polfer, Bruce Culbertson, Lisa Yu, Christine Wu, Takamasa Ito, Yuefeng Huang, Anna-Lena Steckelberg, Hynek Wichterle, and Hachung Chung. Long 3β€²utrs predispose neurons to inflammation by promoting immunostimulatory double-stranded rna formation. Science Immunology, Oct 2023. URL: https://doi.org/10.1126/sciimmunol.adg2979, doi:10.1126/sciimmunol.adg2979. This article has 65 citations and is from a highest quality peer-reviewed journal.

  10. (wutikeli2025elavhurnabindingprotein pages 6-7): Huxitaer Wutikeli, Ting Xie, Wenjun Xiong, and Yin Shen. Elav/hu rna-binding protein family: key regulators in neurological disorders, cancer, and other diseases. RNA Biology, 22:1-11, Feb 2025. URL: https://doi.org/10.1080/15476286.2025.2471133, doi:10.1080/15476286.2025.2471133. This article has 21 citations and is from a peer-reviewed journal.

  11. (mulligan2023themoleculargenetics pages 4-5): Meghan R. Mulligan and Louise S. Bicknell. The molecular genetics of nelavl in brain development and disease. European Journal of Human Genetics, 31:1209-1217, Sep 2023. URL: https://doi.org/10.1038/s41431-023-01456-z, doi:10.1038/s41431-023-01456-z. This article has 54 citations and is from a domain leading peer-reviewed journal.

  12. (mulligan2023themoleculargenetics pages 5-6): Meghan R. Mulligan and Louise S. Bicknell. The molecular genetics of nelavl in brain development and disease. European Journal of Human Genetics, 31:1209-1217, Sep 2023. URL: https://doi.org/10.1038/s41431-023-01456-z, doi:10.1038/s41431-023-01456-z. This article has 54 citations and is from a domain leading peer-reviewed journal.

  13. (o’donovan2020highresolutionepitopemapping pages 2-3): Brian O’Donovan, Caleigh Mandel-Brehm, Sara E Vazquez, Jamin Liu, Audrey V Parent, Mark S Anderson, Travis Kassimatis, Anastasia Zekeridou, Stephen L Hauser, Sean J Pittock, Eric Chow, Michael R Wilson, and Joseph L DeRisi. High-resolution epitope mapping of anti-hu and anti-yo autoimmunity by programmable phage display. Brain Communications, Jul 2020. URL: https://doi.org/10.1093/braincomms/fcaa059, doi:10.1093/braincomms/fcaa059. This article has 73 citations and is from a peer-reviewed journal.

  14. (o’donovan2020highresolutionepitopemapping pages 13-13): Brian O’Donovan, Caleigh Mandel-Brehm, Sara E Vazquez, Jamin Liu, Audrey V Parent, Mark S Anderson, Travis Kassimatis, Anastasia Zekeridou, Stephen L Hauser, Sean J Pittock, Eric Chow, Michael R Wilson, and Joseph L DeRisi. High-resolution epitope mapping of anti-hu and anti-yo autoimmunity by programmable phage display. Brain Communications, Jul 2020. URL: https://doi.org/10.1093/braincomms/fcaa059, doi:10.1093/braincomms/fcaa059. This article has 73 citations and is from a peer-reviewed journal.

  15. (o’donovan2020highresolutionepitopemapping pages 10-10): Brian O’Donovan, Caleigh Mandel-Brehm, Sara E Vazquez, Jamin Liu, Audrey V Parent, Mark S Anderson, Travis Kassimatis, Anastasia Zekeridou, Stephen L Hauser, Sean J Pittock, Eric Chow, Michael R Wilson, and Joseph L DeRisi. High-resolution epitope mapping of anti-hu and anti-yo autoimmunity by programmable phage display. Brain Communications, Jul 2020. URL: https://doi.org/10.1093/braincomms/fcaa059, doi:10.1093/braincomms/fcaa059. This article has 73 citations and is from a peer-reviewed journal.

  16. (o’donovan2020highresolutionepitopemapping pages 1-2): Brian O’Donovan, Caleigh Mandel-Brehm, Sara E Vazquez, Jamin Liu, Audrey V Parent, Mark S Anderson, Travis Kassimatis, Anastasia Zekeridou, Stephen L Hauser, Sean J Pittock, Eric Chow, Michael R Wilson, and Joseph L DeRisi. High-resolution epitope mapping of anti-hu and anti-yo autoimmunity by programmable phage display. Brain Communications, Jul 2020. URL: https://doi.org/10.1093/braincomms/fcaa059, doi:10.1093/braincomms/fcaa059. This article has 73 citations and is from a peer-reviewed journal.

  17. (o’donovan2020highresolutionepitopemapping pages 13-14): Brian O’Donovan, Caleigh Mandel-Brehm, Sara E Vazquez, Jamin Liu, Audrey V Parent, Mark S Anderson, Travis Kassimatis, Anastasia Zekeridou, Stephen L Hauser, Sean J Pittock, Eric Chow, Michael R Wilson, and Joseph L DeRisi. High-resolution epitope mapping of anti-hu and anti-yo autoimmunity by programmable phage display. Brain Communications, Jul 2020. URL: https://doi.org/10.1093/braincomms/fcaa059, doi:10.1093/braincomms/fcaa059. This article has 73 citations and is from a peer-reviewed journal.

  18. (o’donovan2020highresolutionepitopemapping pages 12-13): Brian O’Donovan, Caleigh Mandel-Brehm, Sara E Vazquez, Jamin Liu, Audrey V Parent, Mark S Anderson, Travis Kassimatis, Anastasia Zekeridou, Stephen L Hauser, Sean J Pittock, Eric Chow, Michael R Wilson, and Joseph L DeRisi. High-resolution epitope mapping of anti-hu and anti-yo autoimmunity by programmable phage display. Brain Communications, Jul 2020. URL: https://doi.org/10.1093/braincomms/fcaa059, doi:10.1093/braincomms/fcaa059. This article has 73 citations and is from a peer-reviewed journal.

  19. (o’donovan2020highresolutionepitopemapping media bbad15e1): Brian O’Donovan, Caleigh Mandel-Brehm, Sara E Vazquez, Jamin Liu, Audrey V Parent, Mark S Anderson, Travis Kassimatis, Anastasia Zekeridou, Stephen L Hauser, Sean J Pittock, Eric Chow, Michael R Wilson, and Joseph L DeRisi. High-resolution epitope mapping of anti-hu and anti-yo autoimmunity by programmable phage display. Brain Communications, Jul 2020. URL: https://doi.org/10.1093/braincomms/fcaa059, doi:10.1093/braincomms/fcaa059. This article has 73 citations and is from a peer-reviewed journal.

  20. (o’donovan2020highresolutionepitopemapping media f77dc5fb): Brian O’Donovan, Caleigh Mandel-Brehm, Sara E Vazquez, Jamin Liu, Audrey V Parent, Mark S Anderson, Travis Kassimatis, Anastasia Zekeridou, Stephen L Hauser, Sean J Pittock, Eric Chow, Michael R Wilson, and Joseph L DeRisi. High-resolution epitope mapping of anti-hu and anti-yo autoimmunity by programmable phage display. Brain Communications, Jul 2020. URL: https://doi.org/10.1093/braincomms/fcaa059, doi:10.1093/braincomms/fcaa059. This article has 73 citations and is from a peer-reviewed journal.

  21. (costantino2024elavl3disruptioninb pages 107-112): I Costantino. Elavl3 disruption in amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a neuropathological view. Unknown journal, 2024.

  22. (costantino2024elavl3disruptionina pages 107-112): I Costantino. Elavl3 disruption in amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a neuropathological view. Unknown journal, 2024.

  23. (costantino2024elavl3disruptionina pages 1-7): I Costantino. Elavl3 disruption in amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a neuropathological view. Unknown journal, 2024.

  24. (OpenTargets Search: -ELAVL3): Open Targets Query (-ELAVL3, 5 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.

Artifacts

Citations

  1. mulligan2023themoleculargenetics pages 1-2
  2. mulligan2023themoleculargenetics pages 6-7
  3. mulligan2023themoleculargenetics pages 5-6
  4. mulligan2023themoleculargenetics pages 2-4
  5. negeri2024theroleof pages 39-45
  6. medici2026targetingtherna pages 8-12
  7. mulligan2023themoleculargenetics pages 7-8
  8. wutikeli2025elavhurnabindingprotein pages 6-7
  9. mulligan2023themoleculargenetics pages 4-5
  10. https://doi.org/10.1038/s41431-023-01456-z
  11. https://doi.org/10.1126/sciimmunol.adg2979
  12. https://doi.org/10.1093/braincomms/fcaa059
  13. https://doi.org/10.1038/s12276-024-01328-6
  14. https://doi.org/10.1101/2024.06.13.597128
  15. https://doi.org/10.26508/lsa.202302000
  16. https://doi.org/10.1038/s12276-024-01177-3
  17. https://platform.opentargets.org/target/ENSG00000196361
  18. https://doi.org/10.1038/s41431-023-01456-z,
  19. https://doi.org/10.20381/ruor-30139,
  20. https://doi.org/10.1126/sciimmunol.adg2979,
  21. https://doi.org/10.1080/15476286.2025.2471133,
  22. https://doi.org/10.1093/braincomms/fcaa059,

Perplexity

(ELAVL3-deep-research-perplexity-lite.md)
1. Key Concepts and Definitions Perplexity sonar-pro 13 citations 2025-11-15T18:33:51.769158

ELAVL3 (ELAV-like RNA Binding Protein 3) is a neuron-specific RNA-binding protein in humans, playing a critical role in post-transcriptional gene regulation within the central nervous system. It is essential for neuronal differentiation, maintenance, and synaptic integrity[1][3][5].


1. Key Concepts and Definitions

  • Molecular Function:
    ELAVL3 binds preferentially to GU-rich and AU-rich sequences in intronic regions and 3β€²-untranslated regions (3β€²-UTRs) of target pre-mRNAs[1][3]. This binding regulates alternative splicing, mRNA stability, and transcript abundance, especially for genes involved in glutamate synthesis and neuronal excitability[1][3][5].

  • Protein Domains:
    ELAVL3 contains three RNP-type RNA recognition motifs (RRMs), which are responsible for its RNA-binding activity[1][3][10].

  • RRM1, RRM2, RRM3: These domains mediate binding to AU-rich elements and poly-A tracts in mRNAs[3][10].

  • Biological Processes:

  • Neurogenesis: ELAVL3 is involved in the development and maintenance of neurons[1][3][5].
  • Regulation of mRNA splicing and stability: Influences the expression of genes critical for neurotransmitter synthesis, especially glutamate[1][5].
  • Synapse organization and neuron projection development: Directly regulates transcripts involved in synaptic structure and function[4][5].
  • Cerebellar cell differentiation and maintenance: Highly expressed in Purkinje cells and hippocampus, indicating a role in cerebellar structure[2][5].

  • Cellular Localization:
    ELAVL3 is predominantly localized in the nucleus and cytoplasm of neurons throughout the brain, including the cerebral cortex, hippocampus, cerebellum (especially Purkinje cells), and other regions[2][5][7][10].


2. Recent Developments and Latest Research (2023–2024)

  • Neuroendocrine Cancer:
    ELAVL3 is essential for the development and maintenance of neuroendocrine prostate cancer. RIP-seq analysis identified over 1,100 transcripts bound by ELAVL3, many related to neuronal and RNA-specific processes[4] (Nature Communications, 2023).

  • Brain Development and Disease:
    Recent reviews highlight ELAVL3’s role in brain development and its dysregulation in neurological diseases, including neurodegenerative disorders and paraneoplastic syndromes[6] (European Journal of Human Genetics, 2023).


3. Current Applications and Real-World Implementations

  • Disease Biomarker:
    ELAVL3 is recognized as a Hu antigen and is targeted by anti-Hu antibodies in patients with paraneoplastic encephalomyelitis and sensory neuronopathy (PEM/PSN), making it a diagnostic marker for these autoimmune neurological disorders[1][3].

  • Therapeutic Target:
    The ELAVL3/MYCN positive feedback loop has been identified as a potential therapeutic target in neuroendocrine prostate cancer[4].


4. Expert Opinions and Authoritative Analysis

  • Neuronal Health:
    Disruption of ELAVL3 leads to aberrant splicing events, altered mRNA levels, and compromised glutamate homeostasis, resulting in hyperexcitability and spontaneous seizure activity[1][5].

  • Neurodegeneration:
    ELAVL3 knockout mice exhibit progressive motor deficits, severe cerebellar ataxia, and Purkinje cell axonal degeneration, linking ELAVL3 dysfunction to neurodegenerative processes such as spinocerebellar ataxia[5].


5. Relevant Statistics and Data from Recent Studies

  • Functional Associations:
    ELAVL3 has 5,995 functional associations with biological entities across 8 categories, including molecular profile, disease, phenotype, and structural features, extracted from 90 datasets[1].

  • Transcriptome Binding:
    In neuroendocrine cancer cell lines, ELAVL3 binds over 1,100 transcripts, with enrichment for genes involved in neuron projection development and synapse organization[4].


6. Known Interactions

  • RNA Targets:
    ELAVL3 binds to mRNAs with AU-rich elements, including VEGF mRNA and GAP43 mRNA, stabilizing these transcripts and influencing spatial learning and neuronal maintenance[3][10].

  • Protein Interactions:
    ELAVL3 interacts with other ELAVL family members (e.g., ELAVL4) and proteins involved in RNA processing and neuronal differentiation[3][10].


7. Disease Associations

  • Paraneoplastic Neurological Syndromes:
    ELAVL3 is a target of anti-Hu antibodies in paraneoplastic encephalomyelitis and sensory neuronopathy (PEM/PSN)[1][3].

  • Neurodegenerative Diseases:
    Associations have been reported between ELAVL3 dysfunction and spinocerebellar ataxia, as well as other neurodegenerative conditions characterized by Purkinje cell loss and cerebellar atrophy[5][6].

  • Sensory Peripheral Neuropathy and Limbic Encephalitis:
    ELAVL3 is linked to these diseases through its role as a Hu antigen and its involvement in neuronal maintenance[3].


8. Summary Table

Feature Details Source(s)
Molecular Function RNA-binding (GU-rich, AU-rich), mRNA splicing/stability, glutamate regulation [1][3][10]
Protein Domains 3 RNP-type RNA recognition motifs (RRM1, RRM2, RRM3) [1][3][10]
Biological Process Neurogenesis, synapse organization, neuron projection, cerebellar maintenance [1][2][4][5]
Cellular Localization Nucleus and cytoplasm of neurons (cortex, hippocampus, cerebellum, Purkinje cells) [2][5][7][10]
Known Interactions mRNAs (VEGF, GAP43), ELAVL family proteins [3][10]
Disease Associations Paraneoplastic syndromes, spinocerebellar ataxia, neuroendocrine cancer, neuropathy [1][3][4][5][6]

Key References:
- [Ma'ayan Lab Harmonizome, 2024][1]
- [RNA Biology, 2025][2]
- [GeneCards, 2024][3]
- [Nature Communications, 2023][4]
- [Scientific Reports, 2018][5]
- [Protein Atlas, 2024][7]
- [UniProt, 2024][10]

URLs and Publication Dates:
- Ma'ayan Lab Harmonizome: https://maayanlab.cloud/Harmonizome/gene/ELAVL3 (2024)
- RNA Biology: https://pmc.ncbi.nlm.nih.gov/articles/PMC11926907/ (2025)
- GeneCards: https://www.genecards.org/cgi-bin/carddisp.pl?gene=ELAVL3 (2024)
- Nature Communications: https://www.nature.com/articles/s41598-018-21130-5 (2018)
- Protein Atlas: https://www.proteinatlas.org/ENSG00000196361-ELAVL3 (2024)
- UniProt: https://www.uniprot.org/uniprotkb/Q14576/entry (2024)

If you require more detailed data on specific protein interactions or transcriptome-wide binding profiles, recent high-throughput studies (RIP-seq, CLIP-seq) provide comprehensive lists of ELAVL3 targets in neuronal and cancer contexts[4][8].

Citations

  1. https://maayanlab.cloud/Harmonizome/gene/ELAVL3
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC11926907/
  3. https://www.genecards.org/cgi-bin/carddisp.pl?gene=ELAVL3
  4. https://pmc.ncbi.nlm.nih.gov/articles/PMC10684895/
  5. https://www.nature.com/articles/s41598-018-21130-5
  6. https://www.nature.com/articles/s41431-023-01456-z
  7. https://www.proteinatlas.org/ENSG00000196361-ELAVL3
  8. https://elifesciences.org/articles/10421
  9. https://www.ncbi.nlm.nih.gov/gene/1995
  10. https://www.uniprot.org/uniprotkb/Q14576/entry
  11. https://geneglobe.qiagen.com/us/knowledge/gene/ENSMUSG00000003410
  12. https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=DetailsSearch&Term=1995
  13. https://zfin.org/ZDB-GENE-980526-76

πŸ“š Additional Documentation

Curation Summary

(ELAVL3-curation-summary.md)

ELAVL3 Gene Annotation Curation Summary

Overview

Completed systematic review of all existing GO annotations for human ELAVL3 (HuC), a neuron-specific RNA-binding protein.

Gene Description

ELAVL3 (HuC) is a neuron-specific RNA-binding protein with three RNA recognition motifs (RRMs) that binds to AU-rich elements in the 3'-UTRs of target mRNAs to regulate mRNA stability, alternative splicing, and transcript abundance. It plays essential roles in neuronal differentiation, maintenance, and synaptic integrity, particularly in the cerebellum and hippocampus.

Annotation Review Summary

Accepted Annotations (6)

  1. GO:0140517 (protein-RNA adaptor activity) - IBA
  2. Core molecular function representing ELAVL3's role as an adaptor between RNA and regulatory machinery

  3. GO:0003723 (RNA binding) - IEA

  4. General but accurate molecular function term

  5. GO:0003730 (mRNA 3'-UTR binding) - IEA

  6. Specific and accurate molecular function

  7. GO:0007399 (nervous system development) - IEA

  8. Well-supported biological process

  9. GO:1990904 (ribonucleoprotein complex) - IEA

  10. Appropriate cellular component

  11. GO:0035925 (mRNA 3'-UTR AU-rich region binding) - IEA

  12. Most specific molecular function term

  13. GO:0035925 (mRNA 3'-UTR AU-rich region binding) - IDA (PMID:10710437)

  14. Gold standard experimental evidence for core function

Modified Annotations (2)

  1. GO:0003676 (nucleic acid binding) β†’ GO:0003723 (RNA binding)
  2. Too broad; ELAVL3 specifically binds RNA, not DNA

  3. GO:0030154 (cell differentiation) β†’ GO:0030182 (neuron differentiation)

  4. Too general; ELAVL3 is brain-specific and specifically involved in neuronal differentiation

Removed Annotations (2)

  1. GO:0005515 (protein binding) - IPI (PMID:36950384)
  2. Generic uninformative term from large-scale proteomics study

  3. GO:0005515 (protein binding) - IPI (PMID:37207277)

  4. Same rationale as above

Core Functions Defined

Primary Function

Binds to AU-rich elements in the 3'-UTRs of target mRNAs to regulate their stability, alternative splicing, and abundance, particularly for genes involved in neuronal function and glutamate synthesis.

Key Evidence:
- Direct experimental evidence (PMID:10710437) showing HuC binding to VEGF and c-myc 3'-UTRs
- IBA annotation supporting protein-RNA adaptor activity
- Involvement in nervous system development and neuron differentiation

Cellular Localization

Forms ribonucleoprotein complexes in both nucleus and cytoplasm of neurons.

Key References Used

  • PMID:10710437 - Direct experimental evidence for AU-rich element binding
  • Deep research file - Comprehensive literature review
  • UniProt Q14576 - Protein annotation and domain information

Validation Status

βœ“ File validates successfully with no errors
- Status: COMPLETE
- All 11 annotations reviewed and actioned
- Core functions defined with supporting evidence

πŸ“„ View Raw YAML

id: Q14576
gene_symbol: ELAVL3
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: ELAVL3 (HuC) is a neuron-specific RNA-binding protein with three RNA
  recognition motifs (RRMs) and a hinge/linker region that binds to AU-/U-rich elements
  in the 3'-UTRs of target mRNAs to regulate mRNA stability, alternative splicing,
  alternative polyadenylation (3'-UTR length choice), and transcript abundance. RRM1
  and RRM2 directly associate with AU-rich RNA, while RRM3 promotes transcript stability
  via poly(A)-tail-associated mechanisms. ELAVL3 is predominantly cytoplasmic but
  shuttles between nucleus and cytoplasm via signals in the hinge region. It plays
  essential roles in neuronal differentiation, maintenance, and synaptic integrity,
  particularly in the cerebellum and hippocampus; ELAVL3 loss perturbs splicing programs
  converging on glutamate regulation and neuronal excitability (e.g., AnkG exon 34
  mis-inclusion), producing seizures and cerebellar ataxia in knockout models.
existing_annotations:
- term:
    id: GO:0140517
    label: protein-RNA adaptor activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: IBA annotation for protein-RNA adaptor activity based on phylogenetic
      inference. ELAVL3 functions as an RNA-binding protein that binds AU-rich elements
      in 3'-UTRs and regulates mRNA stability and processing, consistent with adaptor
      activity.
    action: ACCEPT
    reason: This term accurately captures ELAVL3's core molecular function as a protein
      that mediates interactions between RNA molecules and other cellular components
      through its RNA-binding activity. The deep research confirms ELAVL3 "binds preferentially
      to GU-rich and AU-rich sequences in intronic regions and 3'-untranslated regions
      (3'-UTRs) of target pre-mRNAs" and "regulates alternative splicing, mRNA stability,
      and transcript abundance". UniProt confirms it "binds to AU-rich element (ARE)
      sequences of target mRNAs" [PMID:10710437]. IBA annotations are typically well-curated
      and phylogenetically sound.
    supported_by:
    - reference_id: PMID:10710437
      supporting_text: HuC and HuD bind to the VEGF 3'-UTR regulatory segment (VRS)
        and to the c- myc 3'-UTR in a specific and concentration-dependent pattern
    - reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
      supporting_text: ELAVL3 binds preferentially to GU-rich and AU-rich sequences
        in intronic regions and 3'-untranslated regions (3'-UTRs) of target pre-mRNAs.
        This binding regulates alternative splicing, mRNA stability, and transcript
        abundance
    - reference_id: file:human/ELAVL3/ELAVL3-deep-research-falcon.md
      supporting_text: ELAVL3 functions primarily as a post-transcriptional regulator
        that stabilizes target transcripts, in part by binding AU-rich elements and
        influencing poly(A)-tail-associated protection; ELAVL proteins can multimerize
        on RNA and oppose destabilizing factors.
    - reference_id: PMID:37697079
      supporting_text: Binding to RNA targets is facilitated by the RRM1 and RRM2
        domains preferentially recognising AU-rich elements in the 3ΚΉUTR of transcripts
- term:
    id: GO:0003676
    label: nucleic acid binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: IEA annotation for nucleic acid binding based on InterPro domain assignment.
      This is a very general parent term for RNA binding.
    action: MODIFY
    reason: While technically correct (ELAVL3 does bind nucleic acids), this term
      is too broad and uninformative. ELAVL3 specifically binds RNA, not DNA, through
      its three RRM domains. The more specific term GO:0003723 (RNA binding) is already
      annotated and better represents the actual molecular function.
    proposed_replacement_terms:
    - id: GO:0003723
      label: RNA binding
    supported_by:
    - reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
      supporting_text: ELAVL3 contains three RNP-type RNA recognition motifs (RRMs),
        which are responsible for its RNA-binding activity
- term:
    id: GO:0003723
    label: RNA binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: IEA annotation for RNA binding from combined automated annotation methods.
      This is appropriate but less specific than the available AU-rich region binding
      terms.
    action: ACCEPT
    reason: This term accurately describes ELAVL3's core molecular function. ELAVL3
      contains three RRM domains that bind RNA, specifically to AU-rich and GU-rich
      sequences in mRNA 3'-UTRs. While more specific terms exist (mRNA 3'-UTR AU-rich
      region binding), this general RNA binding term is acceptable and correct as
      a broader classification.
    supported_by:
    - reference_id: PMID:10710437
      supporting_text: These proteins bind to AU-rich elements in the 3'-untranslated
        regions (3'-UTRs) of many growth-related mRNAs, including c-myc and VEGF
    - reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
      supporting_text: ELAVL3 contains three RNP-type RNA recognition motifs (RRMs),
        which are responsible for its RNA-binding activity
    - reference_id: PMID:37697079
      supporting_text: All four ELAVL proteins share a common basic structure, of
        three RNA recognition motif (RRM) binding domains and a hinge region
- term:
    id: GO:0003730
    label: mRNA 3'-UTR binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: IEA annotation for mRNA 3'-UTR binding from ARBA machine learning models.
      This accurately captures ELAVL3's specific binding preference for 3'-UTR regions.
    action: ACCEPT
    reason: This is a highly specific and accurate molecular function term for ELAVL3.
      Multiple lines of evidence demonstrate that ELAVL3 preferentially binds to AU-rich
      elements located in the 3'-UTRs of target mRNAs including VEGF and c-myc. This
      is a core molecular function of the protein.
    supported_by:
    - reference_id: PMID:10710437
      supporting_text: HuC and HuD bind to the VEGF 3'-UTR regulatory segment (VRS)
        and to the c- myc 3'-UTR in a specific and concentration-dependent pattern
    - reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
      supporting_text: ELAVL3 binds preferentially to GU-rich and AU-rich sequences
        in intronic regions and 3'-untranslated regions (3'-UTRs) of target pre-mRNAs
- term:
    id: GO:0007399
    label: nervous system development
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: IEA annotation for nervous system development based on UniProtKB keyword
      mapping. ELAVL3 is neuron-specific and plays roles in neuronal differentiation
      and maintenance.
    action: ACCEPT
    reason: This biological process term is well-supported. ELAVL3 is brain-specific
      and essential for neurogenesis, neuronal differentiation, and maintenance of
      neurons. The deep research indicates ELAVL3 is "involved in the development
      and maintenance of neurons" and knockout mice exhibit severe motor deficits
      and cerebellar ataxia. UniProt states it "may be involved in neuronal differentiation
      and maintenance".
    supported_by:
    - reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
      supporting_text: 'Neurogenesis: ELAVL3 is involved in the development and maintenance
        of neurons'
    - reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
      supporting_text: ELAVL3 knockout mice exhibit progressive motor deficits, severe
        cerebellar ataxia, and Purkinje cell axonal degeneration
    - reference_id: PMID:37697079
      supporting_text: As Elavl3βˆ’/βˆ’ mice aged, progressive severe cerebellar ataxia
        was observed
    - reference_id: PMID:37697079
      supporting_text: At the cellular level, Purkinje neurons had disrupted synaptic
        formation, swollen axons, and overall deficits in neuronal transport, highlighting
        the requirement for Elavl3 activity in these neurons
- term:
    id: GO:0030154
    label: cell differentiation
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: IEA annotation for cell differentiation based on UniProtKB keyword mapping.
      This is a very general process term that applies to ELAVL3's role in neuronal
      differentiation.
    action: MODIFY
    reason: While technically correct (ELAVL3 is involved in neuronal differentiation),
      this term is too broad and non-specific. The more precise term would be neuronal
      differentiation or neuron differentiation, which better captures ELAVL3's tissue-specific
      role. Given that ELAVL3 is brain-specific and specifically involved in neurogenesis,
      a more specific term should be used.
    proposed_replacement_terms:
    - id: GO:0030182
      label: neuron differentiation
    supported_by:
    - reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
      supporting_text: 'Neurogenesis: ELAVL3 is involved in the development and maintenance
        of neurons'
    - reference_id: PMID:37697079
      supporting_text: Elavl3 expression is upregulated during the differentiation
        of neural stem cells into inhibitory GABAergic neurons, in parallel with 3’UTR
        lengthening. Depletion of Elavl3 during this differentiation process caused
        a shift towards using proximal polyA sites compared to control cells, with
        a concomitant delay in neural stem cell differentiation
- term:
    id: GO:1990904
    label: ribonucleoprotein complex
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: IEA annotation for ribonucleoprotein complex based on InterPro domain
      assignment. This cellular component term reflects ELAVL3's association with
      RNA as an RNP complex component.
    action: ACCEPT
    reason: This is an appropriate cellular component annotation. ELAVL3 is an RNA-binding
      protein with RRM domains that forms ribonucleoprotein complexes with its target
      mRNAs. The deep research notes ELAVL3 binds over 1,100 transcripts in certain
      contexts, indicating it forms functional RNP complexes. While more specific
      localization terms could be added (nucleus, cytoplasm), this general RNP complex
      annotation is correct.
    supported_by:
    - reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
      supporting_text: In neuroendocrine cancer cell lines, ELAVL3 binds over 1,100
        transcripts, with enrichment for genes involved in neuron projection development
        and synapse organization
    - reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
      supporting_text: ELAVL3 is predominantly localized in the nucleus and cytoplasm
        of neurons throughout the brain
- term:
    id: GO:0035925
    label: mRNA 3'-UTR AU-rich region binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: IEA annotation for mRNA 3'-UTR AU-rich region binding from Ensembl Compara
      orthology transfer. This is the most specific and accurate molecular function
      term for ELAVL3.
    action: ACCEPT
    reason: This is the most precise molecular function annotation for ELAVL3 and
      represents its core biochemical activity. ELAVL3 specifically binds to AU-rich
      elements (AREs) in the 3'-UTRs of target mRNAs. PMID:10710437 experimentally
      demonstrates HuC binding to AU-rich regions in VEGF and c-myc 3'-UTRs. The deep
      research confirms binding to "GU-rich and AU-rich sequences" in 3'-UTRs. This
      annotation captures the key sequence specificity that distinguishes ELAVL3 from
      general RNA-binding proteins.
    supported_by:
    - reference_id: PMID:10710437
      supporting_text: These proteins bind to AU-rich elements in the 3'-untranslated
        regions (3'-UTRs) of many growth-related mRNAs, including c-myc and VEGF
    - reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
      supporting_text: ELAVL3 binds preferentially to GU-rich and AU-rich sequences
        in intronic regions and 3'-untranslated regions (3'-UTRs) of target pre-mRNAs
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:36950384
  review:
    summary: IPI annotation for protein binding based on physical interaction evidence
      from a large-scale proteomics study on autism spectrum disorders.
    action: REMOVE
    reason: While ELAVL3 does interact with proteins (UniProt mentions MAP1B light
      chain LC1, and IntAct shows interactions with DYRK1A, SCN2A, SYNGAP1), the generic
      "protein binding" term is uninformative and does not describe a molecular function.
      This term should not be used unless referring to a specific functional role
      (e.g., as an adapter or scaffold). The reference PMID:36950384 is a large-scale
      protein interaction study where ELAVL3 may have been detected as an interactor,
      but this does not constitute evidence for "protein binding" as a molecular function.
      ELAVL3's primary molecular function is RNA binding, not protein binding.
    supported_by:
    - reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
      supporting_text: "Molecular Function: ELAVL3 binds preferentially to GU-rich\
        \ and AU-rich sequences in intronic regions and 3'-untranslated regions (3'-UTRs)\
        \ of target pre-mRNAs"
    - reference_id: PMID:36950384
      supporting_text: eCollection 2023 Mar 8.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:37207277
  review:
    summary: IPI annotation for protein binding based on physical interaction evidence
      from a large-scale brain cell-type-specific protein interactome study on schizophrenia.
    action: REMOVE
    reason: Same rationale as for PMID:36950384. The generic "protein binding" term
      is uninformative and should be avoided in GO curation. While ELAVL3 does engage
      in protein-protein interactions, this is not its primary molecular function,
      and the term does not provide useful functional information. ELAVL3 is fundamentally
      an RNA-binding protein. Large-scale proteomics studies detect many interactions,
      but these do not necessarily represent the core molecular function of the protein.
    supported_by:
    - reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
      supporting_text: "Molecular Function: ELAVL3 binds preferentially to GU-rich\
        \ and AU-rich sequences in intronic regions and 3'-untranslated regions (3'-UTRs)\
        \ of target pre-mRNAs"
    - reference_id: PMID:37207277
      supporting_text: eCollection 2023 May 19.
- term:
    id: GO:0035925
    label: mRNA 3'-UTR AU-rich region binding
  evidence_type: IDA
  original_reference_id: PMID:10710437
  review:
    summary: IDA annotation for mRNA 3'-UTR AU-rich region binding based on direct
      experimental evidence from PMID:10710437. This is a duplicate of the IEA annotation
      but with stronger experimental evidence.
    action: ACCEPT
    reason: This is the gold standard annotation for ELAVL3 - direct experimental
      evidence (IDA) for its most specific and important molecular function. PMID:10710437
      directly demonstrates using an ELISA-based assay that HuC (ELAVL3) binds to
      AU-rich elements in the 3'-UTRs of VEGF and c-myc mRNAs in a specific and concentration-dependent
      manner. This represents the core biochemical activity of ELAVL3. The experimental
      evidence is robust and the term is maximally informative.
    supported_by:
    - reference_id: PMID:10710437
      supporting_text: I demonstrate that HuC and HuD bind to the VEGF 3'-UTR regulatory
        segment (VRS) and to the c- myc 3'-UTR in a specific and concentration-dependent
        pattern
    - reference_id: PMID:10710437
      supporting_text: These proteins bind to AU-rich elements in the 3'-untranslated
        regions (3'-UTRs) of many growth-related mRNAs, including c-myc and VEGF
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: NAS
  review:
    summary: Added to align core_functions with existing annotations.
    action: NEW
    reason: Core function term not present in existing_annotations. ELAVL3 has a smaller
      nuclear pool that supports roles in splicing and APA, consistent with nucleocytoplasmic
      shuttling driven by hinge-region signals.
    supported_by:
    - reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
      supporting_text: ELAVL3 is involved in the development and maintenance of neurons.
        ELAVL3 binds over 1,100 transcripts in neuroendocrine cancer cell lines, with
        enrichment for genes involved in neuron projection development and synapse
        organization
    - reference_id: UniProtKB:Q14576
      supporting_text: May be involved in neuronal differentiation and maintenance
        (By similarity).
    - reference_id: file:human/ELAVL3/ELAVL3-deep-research-falcon.md
      supporting_text: ELAVL3 is predominantly cytoplasmic but capable of nucleocytoplasmic
        shuttling. A smaller nuclear pool supports roles in splicing and RNA processing,
        while the hinge/linker region contributes to export/localization control.
    - reference_id: PMID:37697079
      supporting_text: Nuclear export and localisation signals located in the hinge
        region of the ELAVL proteins are responsible for the shuttling of RNAs between
        the nucleus and cytoplasm
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: NAS
  review:
    summary: Added to align core_functions with existing annotations.
    action: NEW
    reason: Core function term not present in existing_annotations. nELAVL proteins
      including ELAVL3 are predominantly cytoplasmic where they participate in cytoplasmic
      mRNA stability and translation control.
    supported_by:
    - reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
      supporting_text: ELAVL3 is involved in the development and maintenance of neurons.
        ELAVL3 binds over 1,100 transcripts in neuroendocrine cancer cell lines, with
        enrichment for genes involved in neuron projection development and synapse
        organization
    - reference_id: UniProtKB:Q14576
      supporting_text: May be involved in neuronal differentiation and maintenance
        (By similarity).
    - reference_id: PMID:37697079
      supporting_text: nELAVL proteins are primarily cytoplasmic, with a small fraction
        of nuclear activity, reflecting their roles (for example nuclear export, subcellular
        shuttling)
    - reference_id: file:human/ELAVL3/ELAVL3-deep-research-falcon.md
      supporting_text: ELAVL3 is predominantly cytoplasmic but capable of nucleocytoplasmic
        shuttling.
- term:
    id: GO:0010608
    label: post-transcriptional regulation of gene expression
  evidence_type: NAS
  review:
    summary: Added to align core_functions with existing annotations.
    action: NEW
    reason: Core function term not present in existing_annotations. Falcon-cited literature
      reinforces ELAVL3's role as a post-transcriptional regulator controlling splicing,
      APA/3'-UTR length choice, mRNA stability and translation.
    supported_by:
    - reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
      supporting_text: ELAVL3 is involved in the development and maintenance of neurons.
        ELAVL3 binds over 1,100 transcripts in neuroendocrine cancer cell lines, with
        enrichment for genes involved in neuron projection development and synapse
        organization
    - reference_id: UniProtKB:Q14576
      supporting_text: May be involved in neuronal differentiation and maintenance
        (By similarity).
    - reference_id: PMID:37697079
      supporting_text: RNA-binding proteins (RBPs) are recognised as key regulators
        of post-transcriptional gene regulation, where their binding controls splicing,
        polyadenylation, nuclear export, mRNA stability and translation rate and decay
- term:
    id: GO:0000380
    label: alternative mRNA splicing, via spliceosome
  evidence_type: NAS
  review:
    summary: Added based on falcon-cited literature documenting ELAVL3 regulation
      of neuronal alternative splicing programs.
    action: NEW
    reason: Falcon and Mulligan 2023 (PMID:37697079) document that ELAVL3 regulates
      alternative splicing of neuronal transcripts (e.g., AnkG/ANK3 exon 34) with
      convergence on glutamate-regulation and excitability pathways. This is a core
      molecular process not previously captured in existing_annotations.
    supported_by:
    - reference_id: PMID:37697079
      supporting_text: Elavl3 regulates the embryonic-specific inclusion of vertebrate-specific
        exon 34 in the AnkG transcript.
    - reference_id: PMID:37697079
      supporting_text: High-throughput sequencing analysis of alternative splicing
        in the cerebellum of Elavl3βˆ’/βˆ’ mice highlighted the convergence of targeted
        transcripts on glutamate levels and neuronal excitability
    - reference_id: file:human/ELAVL3/ELAVL3-deep-research-falcon.md
      supporting_text: ELAVL3 has a documented role in alternative splicing; all three
        RRMs plus the hinge region contribute to HuC-dependent splice regulation,
        and ELAVL3 loss alters neuronal splicing programs linked to excitability.
- term:
    id: GO:0110104
    label: mRNA alternative polyadenylation
  evidence_type: NAS
  review:
    summary: Added based on falcon-cited literature documenting ELAVL3 regulation
      of alternative polyadenylation and 3'-UTR length choice in neurons.
    action: NEW
    reason: Multiple sources cited by falcon (Mulligan 2023 PMID:37697079; Dorrity
      2023 PMID:37862432) demonstrate that ELAVL3 (with other nELAVLs) promotes neuronal
      3'-UTR lengthening through distal poly(A) site usage; ELAVL3 depletion shifts
      usage toward proximal sites. This is a distinct molecular process from splicing/stability
      and warrants a separate annotation.
    supported_by:
    - reference_id: PMID:37697079
      supporting_text: Depletion of Elavl3 during this differentiation process caused
        a shift towards using proximal polyA sites compared to control cells, with
        a concomitant delay in neural stem cell differentiation
    - reference_id: PMID:37862432
      supporting_text: the neuron-enriched ELAVL family of genes (ELAVL2, ELAVL3,
        and ELAVL4) can increase (i) 3'UTR length, (ii) dsRNA load, and (iii) activation
        of dsRNA-sensing PRRs such as MDA5, PKR, and TLR3
    - reference_id: file:human/ELAVL3/ELAVL3-deep-research-falcon.md
      supporting_text: ELAVL3 participates in regulation of alternative polyadenylation
        and 3β€²UTR length in neurons. ELAVL3 depletion shifts usage toward proximal
        poly(A) sites, whereas neuronal ELAVL proteins promote longer neuronal 3β€²UTRs.
- term:
    id: GO:0003729
    label: mRNA binding
  evidence_type: NAS
  review:
    summary: Added to align core_functions with existing annotations.
    action: NEW
    reason: Core function term not present in existing_annotations. ELAVL3 binds mRNA
      via three RRM domains; this captures the molecular function used to regulate
      splicing/APA/stability of target mRNAs.
    supported_by:
    - reference_id: PMID:37697079
      supporting_text: All four ELAVL proteins share a common basic structure, of
        three RNA recognition motif (RRM) binding domains and a hinge region
    - reference_id: PMID:37697079
      supporting_text: Binding to RNA targets is facilitated by the RRM1 and RRM2
        domains preferentially recognising AU-rich elements in the 3ΚΉUTR of transcripts
# GO:0048167 (regulation of synaptic plasticity) NEW annotation REMOVED
# per PR #684 review feedback. The evidence (disrupted Purkinje neuron
# synaptic formation in Elavl3-/- mice) is an indirect phenotypic
# consequence of losing an RNA-binding regulator, not direct molecular
# evidence that ELAVL3 itself regulates synaptic plasticity. Using a proxy
# GO term because the ideal "regulation of neuronal excitability" term is
# absent is not sound curation practice; moved to proposed_new_terms below.
core_functions:
- description: Binding to AU-rich and GU-rich elements in mRNA 3'-UTRs to stabilize
    target transcripts and regulate alternative splicing events in neurons
  molecular_function:
    id: GO:0035925
    label: mRNA 3'-UTR AU-rich region binding
  directly_involved_in:
  - id: GO:0030182
    label: neuron differentiation
  - id: GO:0007399
    label: nervous system development
  - id: GO:0010608
    label: post-transcriptional regulation of gene expression
  locations:
  - id: GO:0005634
    label: nucleus
  - id: GO:0005737
    label: cytoplasm
  anatomical_locations:
  - id: UBERON:0002129
    label: cerebellar cortex
  - id: UBERON:0002421
    label: hippocampal formation
  substrates:
  - id: UniProtKB:P15692
    label: VEGFA mRNA
  - id: UniProtKB:P01106
    label: MYC mRNA
  - id: UniProtKB:P17677
    label: GAP43 mRNA
  supported_by:
  - reference_id: PMID:10710437
    supporting_text: With this assay, I demonstrate that HuC and HuD bind to the VEGF
      3'-UTR regulatory segment (VRS) and to the c- myc 3'-UTR in a specific and concentration-dependent
      pattern, with both proteins showing a greater affinity for the VRS
  - reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
    supporting_text: ELAVL3 binds preferentially to GU-rich and AU-rich sequences
      in intronic regions and 3'-untranslated regions (3'-UTRs) of target pre-mRNAs.
      This binding regulates alternative splicing, mRNA stability, and transcript
      abundance
  - reference_id: UniProtKB:Q14576
    supporting_text: RNA-binding protein that binds to AU-rich element (ARE) sequences
      of target mRNAs, including VEGF mRNA. Plays a role in the stabilization of GAP43
      mRNA and in spatial learning
  in_complex:
    id: GO:1990904
    label: ribonucleoprotein complex
- description: Regulating neuronal alternative splicing and alternative polyadenylation/3'-UTR
    length choice of target transcripts, including AnkG/ANK3 exon 34 and a broader
    program of glutamate-regulating and excitability-related transcripts
  molecular_function:
    id: GO:0003729
    label: mRNA binding
  directly_involved_in:
  - id: GO:0000380
    label: alternative mRNA splicing, via spliceosome
  - id: GO:0110104
    label: mRNA alternative polyadenylation
  - id: GO:0010608
    label: post-transcriptional regulation of gene expression
  locations:
  - id: GO:0005634
    label: nucleus
  - id: GO:0005737
    label: cytoplasm
  anatomical_locations:
  - id: UBERON:0002129
    label: cerebellar cortex
  - id: UBERON:0001870
    label: frontal cortex
  supported_by:
  - reference_id: PMID:37697079
    supporting_text: Elavl3 regulates the embryonic-specific inclusion of vertebrate-specific
      exon 34 in the AnkG transcript.
  - reference_id: PMID:37697079
    supporting_text: High-throughput sequencing analysis of alternative splicing in
      the cerebellum of Elavl3βˆ’/βˆ’ mice highlighted the convergence of targeted transcripts
      on glutamate levels and neuronal excitability
  - reference_id: PMID:37862432
    supporting_text: the neuron-enriched ELAVL family of genes (ELAVL2, ELAVL3, and
      ELAVL4) can increase (i) 3'UTR length, (ii) dsRNA load, and (iii) activation
      of dsRNA-sensing PRRs such as MDA5, PKR, and TLR3
  - reference_id: file:human/ELAVL3/ELAVL3-deep-research-falcon.md
    supporting_text: ELAVL3 has a documented role in alternative splicing; all three
      RRMs plus the hinge region contribute to HuC-dependent splice regulation, and
      ELAVL3 loss alters neuronal splicing programs linked to excitability.
  in_complex:
    id: GO:1990904
    label: ribonucleoprotein complex
- description: Adapting AU-rich mRNA transcripts to post-transcriptional regulatory
    complexes to control neuronal gene expression programs
  molecular_function:
    id: GO:0140517
    label: protein-RNA adaptor activity
  directly_involved_in:
  - id: GO:0030182
    label: neuron differentiation
  - id: GO:0007399
    label: nervous system development
  - id: GO:0010608
    label: post-transcriptional regulation of gene expression
  locations:
  - id: GO:0005634
    label: nucleus
  - id: GO:0005737
    label: cytoplasm
  anatomical_locations:
  - id: UBERON:0002129
    label: cerebellar cortex
  - id: UBERON:0002421
    label: hippocampal formation
  supported_by:
  - reference_id: file:human/ELAVL3/ELAVL3-deep-research-perplexity-lite.md
    supporting_text: ELAVL3 is involved in the development and maintenance of neurons.
      ELAVL3 binds over 1,100 transcripts in neuroendocrine cancer cell lines, with
      enrichment for genes involved in neuron projection development and synapse organization
  - reference_id: UniProtKB:Q14576
    supporting_text: May be involved in neuronal differentiation and maintenance.
      Plays a role in the stabilization of GAP43 mRNA
  in_complex:
    id: GO:1990904
    label: ribonucleoprotein complex
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms.
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara.
  findings: []
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning models
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods.
  findings: []
- id: PMID:10710437
  title: RNA-binding analyses of HuC and HuD with the VEGF and c-myc 3'-untranslated
    regions using a novel ELISA-based assay.
  findings: []
- id: PMID:36950384
  title: Protein interaction studies in human induced neurons indicate convergent
    biology underlying autism spectrum disorders.
  findings: []
- id: PMID:37207277
  title: Using brain cell-type-specific protein interactomes to interpret neurodevelopmental
    genetic signals in schizophrenia.
  findings: []
- id: PMID:37697079
  title: The molecular genetics of nELAVL in brain development and disease.
  findings:
  - statement: ELAVL3 is the only nELAVL expressed in Purkinje neurons; Elavl3 knockout
      mice develop progressive cerebellar ataxia with disrupted Purkinje synaptic
      formation, swollen axons, and neuronal transport deficits, and Elavl3+/- and
      -/- mice show seizure activity.
    supporting_text: As Elavl3βˆ’/βˆ’ mice aged, progressive severe cerebellar ataxia
      was observed. This ataxia caused an abnormal step cycle, tremor and over time,
      impaired postural reflexes. At the cellular level, Purkinje neurons had disrupted
      synaptic formation, swollen axons, and overall deficits in neuronal transport,
      highlighting the requirement for Elavl3 activity in these neurons
    reference_section_type: RESULTS
  - statement: ELAVL3 regulates alternative splicing of neuronal transcripts converging
      on glutamate regulation and excitability, including embryonic-specific inclusion
      of AnkG exon 34; ELAVL3 also drives 3'-UTR lengthening via distal poly(A) site
      usage during inhibitory neuron differentiation.
    supporting_text: High-throughput sequencing analysis of alternative splicing in
      the cerebellum of Elavl3βˆ’/βˆ’ mice highlighted the convergence of targeted transcripts
      on glutamate levels and neuronal excitabilityβ€”linking RNA regulation to the
      seizure activity observed in Elavl3βˆ’/βˆ’ mice
    reference_section_type: RESULTS
  - statement: All four ELAVL proteins share three RNA recognition motifs (RRMs)
      with a hinge region; RRM1 and RRM2 directly bind AU-rich elements in 3'-UTRs,
      while RRM3 supports transcript stability via poly(A)-associated mechanisms.
    supporting_text: Binding to RNA targets is facilitated by the RRM1 and RRM2 domains
      preferentially recognising AU-rich elements in the 3ΚΉUTR of transcripts
    reference_section_type: LITERATURE_REVIEW
- id: PMID:37862432
  title: Long 3'UTRs predispose neurons to inflammation by promoting immunostimulatory
    double-stranded RNA formation.
  findings:
  - statement: The neuron-enriched ELAVL family (ELAVL2, ELAVL3, ELAVL4) collectively
      drives 3'-UTR lengthening in human neurons, which in turn raises dsRNA load
      and tonically activates dsRNA-sensing PRRs (MDA5, PKR, TLR3).
    supporting_text: the neuron-enriched ELAVL family of genes (ELAVL2, ELAVL3, and
      ELAVL4) can increase (i) 3'UTR length, (ii) dsRNA load, and (iii) activation
      of dsRNA-sensing PRRs such as MDA5, PKR, and TLR3
    reference_section_type: ABSTRACT
- id: PMID:32954318
  title: High-resolution epitope mapping of anti-Hu and anti-Yo autoimmunity by programmable
    phage display.
  findings:
  - statement: ELAVL3/HuC is one of the neuronal ELAVL (nELAVL) proteins targeted
      by anti-Hu paraneoplastic autoantibodies; the dominant immunodominant epitope
      maps to a 17-residue motif in the hinge region between RRM2 and RRM3 shared
      across ELAVL2/3/4, with most enriched peptides (>80%) attributed to ELAVL4.
    supporting_text: A majority (>90%) of the significantly enriched nELAVL peptides
      converged upon on a 17-residue sequence at AA positions 276–294 of ELAVL4, a
      sequence which is also common to variants of ELAVL2 and ELAVL3
    reference_section_type: RESULTS
- id: PMID:40000387
  title: ELAV/Hu RNA-binding protein family - key regulators in neurological disorders,
    cancer, and other diseases.
  findings:
  - statement: ELAVL3 is restricted to the nervous system, essential for cerebellar
      function, and involved in neuronal differentiation and excitability; ELAVL3
      dysregulation is associated with epilepsy.
    supporting_text: Both Elavl3 and Elavl4 are restricted to the nervous system and
      are involved in neuronal differentiation and excitability. Elavl3 is essential
      for cerebellar function and has been associated with epilepsy
    reference_section_type: ABSTRACT
- id: file:human/ELAVL3/ELAVL3-deep-research-falcon.md
  title: 'Falcon (Edison Scientific Literature) deep research report: ELAVL3 (HuC)
    functional annotation'
  findings:
  - statement: ELAVL3 functions as a post-transcriptional regulator that uses three
      RRMs plus a hinge region to bind AU-/U-rich elements in 3'-UTRs, with RRM3 contributing
      poly(A)-tail binding; functions span splicing, APA/3'-UTR length, mRNA stability,
      and translation. ELAVL3 is predominantly cytoplasmic with nucleocytoplasmic
      shuttling.
    supporting_text: ELAVL3 functions primarily as a post-transcriptional regulator
      that stabilizes target transcripts, in part by binding AU-rich elements and
      influencing poly(A)-tail-associated protection; ELAVL proteins can multimerize
      on RNA and oppose destabilizing factors.
    reference_section_type: OTHER
  - statement: ELAVL3 has a documented role in alternative splicing in which all three
      RRMs plus the hinge region contribute to HuC-dependent splice regulation; ELAVL3
      loss alters neuronal splicing programs linked to excitability.
    supporting_text: ELAVL3 has a documented role in alternative splicing; all three
      RRMs plus the hinge region contribute to HuC-dependent splice regulation, and
      ELAVL3 loss alters neuronal splicing programs linked to excitability.
    reference_section_type: OTHER
  - statement: ELAVL3 participates in alternative polyadenylation control of neuronal
      3'-UTR length; ELAVL3 depletion shifts poly(A) usage toward proximal sites.
    supporting_text: ELAVL3 participates in regulation of alternative polyadenylation
      and 3β€²UTR length in neurons. ELAVL3 depletion shifts usage toward proximal poly(A)
      sites, whereas neuronal ELAVL proteins promote longer neuronal 3β€²UTRs.
    reference_section_type: OTHER